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II Summary  
Summary 
The catabolite control protein CcpA is the main regulator of carbon catabolite repression and 
activation in low-GC Gram-positive bacteria. In the presence of glucose, CcpA regulates 
gene expression by binding to so-called catabolite responsive elements (cre) located 
upstream of, or within the promoter regions of the regulated genes. CcpA has been 
extensively studied in different bacteria, and was found to not only regulate metabolic genes 
but also to control virulence and antimicrobial resistance. In this study, we analysed the role 
of CcpA in the pathogen Staphylococcus aureus.  
Transcriptome analyses showed that more than 150 genes in the exponential growth phase 
were regulated by glucose in a CcpA-dependent manner, and that even in the absence of 
glucose, CcpA regulated more than 200 genes. Many of the regulated genes encode 
metabolic enzymes, suggesting that CcpA plays a similar role in S. aureus as it does in other 
bacteria. However, we also found some aspects of the CcpA regulon, which were specific for 
S. aureus. 
The S. aureus CcpA was also involved in the regulation of some important virulence factors. 
Glucose-dependent repression of hla-, spa-, and tst-expression, coding for α-hemolysin, 
protein A, and toxic shock syndrome toxin, respectively, was dependent on CcpA. The 
presence of putative cre-sites in the promoter regions of these genes suggested that they 
were under direct control of CcpA. In contrast, the glucose-mediated and CcpA-dependent 
downregulation of the capsule genes (cap) was probably indirect. Deletion ccpA reduced the 
transcription of RNAIII, which is the effector molecule of the agr operon and regulates the 
expression of many exoproteins and cell wall associated proteins. The deletion was also 
found to significantly reduce methicillin resistance and a ∆ccpA mutant was significantly 
more susceptible to teicoplanin. 
Moreover, deletion of ccpA abolished the capacity to form a biofilm under static and flow 
conditions, and was linked to decreased expression of icaA, a gene responsible for the 
expression of PIA, an important component of the S. aureus biofilm matrix. Repression of 
icaA was presumably achieved via the upregulation of the TCA cycle genes citB and citZ in 
the ∆ccpA mutant. Loss of biofilm formation in the mutant also correlated with decreased 
cidA transcription, recently reported to contribute to the production of extracellular DNA, 
which is a further component of the S. aureus biofilm matrix.  
The finding that S. aureus virulence and carbohydrate utilization are directly linked through 
CcpA shows an important mechanism, by which this pathogen modulates virulence factor 
production in response to changes in its environment. 
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Zusammenfassung 
In Gram-positiven Bakterien wird Kohlenstoff-Katabolitrepression hauptsächlich durch das 
Katabolitenkontrollprotein CcpA bewirkt. In Anwesenheit von Glukose bindet CcpA an 
spezielle DNA-Sequenzen, ober- oder unterhalb des Transkriptionsstartes bestimmter Gene 
und reguliert somit deren Expression. Umfangreiche Untersuchungen in verschiedenen 
Gram-positiven Bakterien haben gezeigt, dass CcpA nicht nur Gene des Stoffwechsels 
reguliert, sondern auch an der Regulation von Virulenz und Antibiotikaresistenz beteiligt ist. 
Diese Studie untersucht erstmals die Rolle von CcpA im pathogenen Bakterium 
Staphylococcus aureus.  
Eine Transkriptomanalyse zeigte, dass CcpA in Abhängigkeit von Glukose über 150 Gene 
reguliert. Interessanterweise wurden bereits ohne Glucose über 200 Gene durch CcpA 
kontrolliert. Die meisten regulierten Gene kodieren Enzyme des Stoffwechsels, was darauf 
hindeutet, dass CcpA in S. aureus eine ähnliche Rolle spielt wie in anderen Gram-positiven 
Bakterien.  
Zudem konnte nachgewiesen werden, dass CcpA die Expression wichtiger Virulenzfaktoren 
von S. aureus kontrolliert. So war die durch Glukose induzierte Repression der hla, spa und 
tst-Gene, welche für α-Hämolysin, Protein A und Toxic Shock Syndrome Toxin kodieren, 
abhängig von CcpA. Die Anwesenheit potentieller CcpA-Bindestellen in den 
Promoterregionen dieser Gene weist auf direkte Kontrolle durch CcpA hin. Im Gegensatz 
dazu scheint die durch Glukose induzierte und von CcpA abhänginge Repression der 
Kapselgene indirekt zu sein. Die Inaktivierung des ccpA-Genes führte ausserdem zu einer 
signifikanten Reduktion der Transkription von RNAIII, dem Effektormolekül des agr-operons 
welches die Expression vieler Exoproteine und zellwandassoziierter Protein kontrolliert. Auch 
verringerte die Deletion von ccpA die Resistenzhöhe gegenüber Methicillin und Teicoplanin. 
Ferner reduzierte die Inaktivierung von ccpA die Fähigkeit von S. aureus einen Biofilm zu 
bilden und konnte mit reduzierter icaA-Expression in Verbindung gebracht werden. IcaA ist 
Teil des ica-Operons, welches für die Bildung von PIA verantwortlich ist, einer wichtigen 
Komponente des S. aureus Biofilms. Die beobachtete icaA-Repression und auch die 
verminderte PIA-Bildung in der Mutante wurden wahrscheinlich über die Hochregulierung der 
Krebszyklusgene citZ und citB bewirkt. Ausserdem korrelierte die verminderte Biofilmbildung 
der Mutante mit reduzierter Transkription von cidA, einem Gen welches an der Produktion 
extrazellulärer DNA (eDNA) beteiligt ist. eDNA ist ein weiterer Bestandteil der S. aureus 
Biofilmmatrix.  
S. aureus CcpA stellt somit ein wichtiges Bindeglied zwischen Virulenz und Metabolismus 
dar, welches es dem Bakterium ermöglicht die Produktion wichtiger Virulenzfaktoren auf die 
gegebenen Bedingungen in seiner Umgebung abzustimmen. 
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1 Introduction 
1.1 Staphylococcus aureus 
Staphylococcus aureus is a factultative anaerobic, Gram-positive bacterium belonging to the 
family of Micrococcaceae. It may appear as a commensal on human skin and colonizes up to 
30 % of the healthy population, usually in the nares (4). However, it is capable of producing a 
wide array of virulence factors and therefore it commonly causes a variety of diseases 
ranging from superficial lesions to systemic and life-threatening infections such as 
osteomyelitis, endocarditis, pneumonia and septicaemia. The difficulties in fighting this 
pathogen are the increase in resistance to antibacterial agents together with its increasing 
prevalence as a nosocomial pathogen (4). The bacterium can adapt to new conditions very 
quickly, because it is able to aquire new genetic information through gene exchange with 
other bacteria (117). 
1.1.1 Virulence 
Archer (4) proposed five stages for the pathogenesis of S. aureus: colonization, local 
infection, systemic dissemination and/or sepsis, metastatic infection and toxinosis. At each of 
the different stages, S. aureus encounters the immune response of the host. However, S. 
aureus is able to produce a wide array of virulence factors, which specifically influence the 
host's function and immune response to allow the pathogen to successfully survive in the 
host. The main mechanisms the pathogen uses to overcome immune responses are (41): 
1. Inhibition of neutrophil chemotaxis 
2. Killing of leukocytes 
3. Resistance to phagocytosis 
4. Resistance to killing by antimicrobial peptides  
5. Resistance to killing by lysozyme 
6. Ability to survive in neutrophil phagosomes 
7. Production of immunomodulatory molecules 
8. Subversion of the humoral immune response 
 
1. Inhibition of neutrophil chemotaxis 
When the bacterium starts to grow in the host, chemoattractants are liberated and are 
recognized by neutrophils at very low concentrations. Stimulation of the neutrophils activates 
intracellular signalling cascades, resulting in the migration of more neutrophils to the site of 
infection. The chemotaxis inhibitory protein of staphylococci CHIPS blocks the receptors for 
the chemotactic signals on the neutrophils and thereby prevents the recruitment of more 
neutrophils (30). The extracellular adherence protein Eap blocks the intercellular adhesion 
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molecule-1 on the surface of endothelial cells and thereby prevents leukocyte adhesion, 
diapedesis and extravasation (20).  
 
2. Killing of leukocytes 
Cytolytic toxins produced by S. aureus form pores in the cytoplasmic membranes of 
leukocytes and/or erythrocytes and finally lead to lysis. These toxins comprise α-toxin (Hla), 
and the bicomponent leukotoxins with γ-hemolysin (Hlg), the Panton-Valentine leukocidin 
(PVL), leukocidin E/D and leudkocidin M/F-PV-like (104).  
 
3. Resistance to phagoytosis 
Protein A (encoded by spa), a protein that is anchored in the cell wall of S. aureus, binds 
immunoglobulin G molecules the wrong way round by a non-immune mechanism. This 
disrupts opsonization and phagocytosis (103, 138). The expression of clumping factor A 
(ClfA), a fibrinogen-binding protein, was shown to protect S. aureus from phagocytosis (102). 
However, fibrinogen seems not to be necessary for the protective properties of ClfA and the 
exact mechanism by which ClfA protects S. aureus from phagocytosis is not fully understood 
(101). Microcapsules, which are produced by most clinical S. aureus isolates, were shown to 
reduce the uptake by neutrophils (130). In addition, S. aureus has the ability to inactivate the 
complement system by several mechanisms. The Stahylococcus complement inhibitor 
(SCIN), the extracellular fibrinogen-binding protein Efb and staphylokinase (Sak) inactivate 
different factors of the complement and in this way block opsonization and/or phagocytosis 
by neutrophils (75, 112, 113).  
 
4. Resistance to killing by antimicrobial peptides  
Resistance to killing by antimicrobial peptides inside a neutrophil by S. aureus is achieved 
through natural modifications of the cell surface. Dlt modifies wall teichoic acid and 
lipoteichoic acid in a way that the negative charge of the cell surface is partially neutralized 
by D-Ala esterification and the cell is thus less attractive to cationic molecules (107). MprF 
modifies phosphatidylglycerol to lysylphosphatidylglycerol and thereby increases the positive 
charge and also reduces the affinity towards antimicrobial peptides (106). S. aureus is also 
able to secrete proteins that neutralize cationic peptides. For example, binding of 
staphylokinase to the defensins abolishes their bactericidal properties and the extracellular 
metalloprotease aureolysin cleaves and inactivates a human defensin (64, 126).  
 
 
 
 
 1 Introduction 3  
5. Resistance to killing by lysozyme 
Lysozyme is a muramidase that cleaves peptidoglycan and is produced by various tissues of 
the host. It is present in body fluids, such as serum, saliva, sweat and tears and its titre is 
increased by infection. An increase in lysozyme concentration in blood is an indicator for 
monocyte and granulocyte proliferation. Lysozyme is therefore an important compound of the 
innate immune defence of the host. S. aureus is completely insensitive to lysozyme. Due to 
O-acetylation of the muramic acid of the peptidoglycan through a membrane bound O-
acetyltransferase (8). This mechanism greatly contributes to the persistence and success of 
S. aureus in colonizing humans and animals. 
 
6. Ability to survive in neutrophil phagosomes 
Once S. aureus is engulfed by phagocytosis, it has to face superoxide radicals which are 
produced by the neutrophils. S. aureus has several mechanisms to avoid the lethal effects of 
these free oxygen radicals, such as the production of carotenoid pigments, which give S. 
aureus its golden colour (77). Other oxidative stress resistance enzymes of S. aureus 
comprise superoxide dismutase, catalase (KatA), alkyl hydroperoxide reductase (AhpC), 
thiol-dependent peroxidase (Bcp), and thioredoxin reductase (TrxB) (27, 66). 
 
7. Production of immunomodulatory molecules 
Furthermore, S. aureus is able to express toxins which act as superantigens (SAgs). SAgs, 
unlike conventional peptide antigens, bind to invariant regions of the major histocompatibility 
complex (MHC) class II molecules at the surface of antigen-presenting cells outside of the 
classical antigen-binding groove and also to invariant regions of the T-cell receptor (Fig. 1) 
(108). This leads to activation of T-cells at orders of magnitude above antigen-specific 
activation, resulting in a massive cytokine release, which in turn leads to capillary leakage 
and is believed to be responsible for hypotension, shock, and finally death. Staphylococcal 
superantigens comprise the toxic shock syndrome toxin (TSST-1), exfoliatins A and B, and 
various staphylococcal enterotoxins (SEs).  
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Figure 1: Mechanism of action of 
superantigens. Left: Normal antigens 
bind to specific sites of the MHC 
class II molecules of antigen-
presenting cells (APC) and thereby 
lead to the activation of T-cells. 
Right: Unspecific binding of 
superantigens to the MHC class II 
molecule and also to an invariant 
region of the T-cell-receptor (TCR) 
leads to the activation of massive 
amounts of T-cells (adapted from 
(41)). 
 
 
 
8. Subversion of the humoral immune response 
By binding to platelets and thereby stimulating their activation, S. aureus can subverse the 
humoral immune response of the host. Platelet activation is achieved by fibronectin binding 
protein A or ClfA or B (55, 87, 125). Contact is made with the platelet through a bridge of 
fibronectin or fibrinogen which bind to S. aureus binding proteins on the one hand and to 
platelet receptors (integrins) on the other hand. Platelet activation requires the binding of 
antibodies to ClfA/B or fibronectin-binding proteins. These antibodies are found in almost all 
humans at low levels and can be exploited by the bacterium. S. aureus can thus grow in 
platelet-fibrin thrombi and thereby escape the attention of neutrophils. This is probably an 
important virulence mechanism in the pathogenesis of infective endocarditis (125). 
 
In addition to the factors, which overcome the host’s immune response, S. aureus also 
produces various enzymes such as proteases, nucleases, lipases, and hyaluronate lyase, 
which allow the invasion of the host tissue. Host fatty acids, which act as detergents and 
thereby interfere with bacterial growth, are overcome by fatty acid modifying enzymes 
(FAME) (94). Binding proteins for fibrinogen, fibronectin, laminin, collagen, vitronectin and 
thrombospondin promote attachment to endothelial cells and the basement membrane (43). 
Specific toxinosis is caused by enterotoxins or the exfoliative toxin which causes the 
staphylococcal scalded skin syndrome (SSSS) (4). Figure 2 summarizes the virulence 
factors of S. aureus. 
 
 
 
 
 
 
 
T-cell
APC
SuperantigenAntigen
TCR
MHC class II
Signal 
transduction
Signal 
transduction
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Figure 2: Overview of the S. aureus virulence factors (adapted from (41, 42)). 
 
The virulence factors of S. aureus contribute to a wide array of infections. The bacterium is 
the most common agent for furuncles/carbuncles, impetigo, surgical wound infections, 
pyomyositis (infection of skeletal muscles), botryomycosis (chronic granulomatous infection 
of skin or viscera), acute/right-sided endocarditis, epidural abscesses, toxic shock syndrome 
and scalded skin syndrome. But also cellulitis, hospital acquired bacteraemia, hematogenous 
osteomyelitis, septic arthritis, brain abscesses, hospital-acquired pneumonia, empyema (pus 
and fluid in the body cavity), septic shock, food-borne gastroenteritis and renal carbuncles 
are caused by this pathogen (4). Because some of the virulence factors of S. aureus are 
located on mobile genetic elements such as pathogenicity islands (e.g. TSST-1) or lysogenic 
bacteriophages (e.g. PVL), they can easily spread by horizontal gene transfer (42).  
1.1.2 Antibiotic resistance  
Since the discovery of the β-lactam penicillin by Alexander Flemming in 1928, many new 
antibiotics have been developed. However, their introduction was always accompanied by a 
rapid appearance of resistant bacteria (145). Resistance mechanisms are all based on either 
inactivation of the antibiotic, prevention of the antibiotic to reach its target, or alteration of the 
target of the antibiotic by mutation, modification or overexpression (10). All these 
mechanisms emerge either through the mutation of existing genes or by the acquisition of 
new resistance determinants. The fact that bacteria occur in high numbers, have short 
generation times and possess efficient mechanisms for gene exchange favours the rapid 
evolution of resistance or even multi resistance. Table 1 summarizes the most common 
antibiotics, their mode of action and resistance mechanisms in S. aureus. 
 
 
Capsule
Cytolytic enzymes and toxins
Adhesion, blood clot, 
damaged tissue
Cell membrane damage 
antiphagocytic defences
cytokine release by platelets and 
leukocytes
Surface protein adhesins
Impediment of phagocytosis
Protein A
Disruption of opsonization and phagocytosis
Human IgG
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Table 1: Main antibacterial classes, mechanisms of action and resistance mechanisms. 
Antibacterial class 
(examples) 
Principal target Resistance mechanisms in  
S. aureus 
   
Aminoglycosides 
(Kanamycin, Gentamicin) 
Protein synthesis: initiation 
complex/translation 
Aminoglycoside modifying 
enzymes (141) 
   
β-lactams 
(Penicillin, Methicillin) 
Cell wall synthesis: 
transpeptidation of 
peptidoglycan 
β-lactamases, low-affinity PBP 
2a, PBP alteration (mutation, 
overexpression) (141) 
   
Chloramphenicol Protein synthesis: peptidyl 
transferase 
Chloramphenicol 
acetyltransferase, efflux, 
multidrug transporters (119) 
   
Fusidic acid Protein synthesis: elongation 
factor G 
Chromosomal mutations, 
impermeability, inactivation, efflux 
(136) 
   
Glycopeptides 
(Vancomycin, Teicoplanin) 
Cell wall synthesis: 
transpeptidation and 
transglycosylation of 
peptidoglycan 
D-alanyl-D-lactate-containing 
peptidoglycan precursors (vanA), 
higher cell wall D-ala-D-ala 
content (10, 141) 
   
Macrolides, lincosamides, 
streptogramins B and ketolides 
(Erythromycin, Clindamycin) 
Protein synthesis: 50S 
ribosome 
23S rRNA methylase, efflux, 
macrolide phosphotransferase, 
lincosamide 
nucleotidyltransferase, 
acetyltransferase (38, 73, 141) 
   
Mupirocin Protein synthesis: isoleucyl-
tRNA synthetase 
Acquired isoleuyl-tRNA 
synthetase, chromosomal 
mutations ileS (39) 
   
Oxazolidinones 
(Linezolid) 
Protein synthesis: 50S 
ribosome 
Mutational alterations of 23S 
rRNA gene (141) 
   
Quinolones 
(Ciprofloxacin) 
Nucleic acid synthesis: DNA 
gyrase or topoisomerase IV 
Altered gyrase, topoisomerase IV, 
efflux (58) 
   
Rifampicin Nucleic acid synthesis: RNA 
polymerase 
Chromosomal mutations in rpoB 
(95) 
   
Sulfonamindes/ Trimethoprim 
(Sulfisoxazol, 
Sulfamethoxazole, 
Trimethoprim) 
Folate metabolism: depletion of 
folate pool 
Chromosomal mutations, 
acquired dihydrofolate reductase 
(114) 
   
Tetracyclines 
(Tetracycline) 
Protein synthesis: ribosomal A 
site 
Efflux, ribosomal protection (25, 
141) 
 
The most widely used antibiotics are the β-lactams, which inhibit biosynthesis of the 
peptidoglycan, the main component of the cell wall. The major subunit of the peptidoglycan is 
N-acetylglucosamine-β-1,4-N-acetylmuramyl-pentapeptide, a disaccharide with a stem 
peptide. These units are crosslinked by transpeptidation and transglycosylation, which is 
achieved through the so-called penicillin-binding proteins (PBPs). β-lactam antibiotics are 
structural analogues of the terminal D-alanyl-D-alanine of the stem peptide. Therefore, they 
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are recognized by the PBPs, bind and thereby inactivate their transpeptidation domains. 
However, already in the early 1950s, S. aureus treatment with penicillin was threatened 
through the emergence of penicillin resistant strains. These strains express β-lactamases, 
which inactivate β-lactams via hydrolysis. Methicillin, a semisynthetic β-lactam, is resistant to 
β-lactamases and was introduced in the 1960s. However, only shortly afterwards, methicillin 
resistance was reported (63). Methicillin resistance in staphylococci is mainly mediated by 
the methicillin resistance determinant mecA, that codes for a low-affinity PBP, called PBP 2a 
(137). This PBP allows peptidoglycan biosynthesis in the presence of β-lactams (85). 
However, methicillin resistance is not only dependent on mecA expression, but also on a 
whole series of chromosomally encoded factors (11, 31). These factors were initially termed 
fem (factors essential for methicillin resistance) (9) or aux (auxiliary) factors (31). They are 
present in resistant and susceptible strains and their inactivation has different impacts on 
methicillin resistance, ranging from complete hypersusceptibility down to lesser effects.  
Today, two categories of methicillin-resistant S. aureus (MRSA) are recognized. Hospital-
acquired MRSA (HA-MRSA) are the leading cause of nosocomial infections worldwide, 
especially in intensive care units. Probably because of their continuous exposure to 
antibiotics in hospitals, they have become multiresistant. They were found to carry 
superantigenic exotoxins and staphylococcal enterotoxin A as major virulence factors (133). 
Community-acquired MRSA (CA-MRSA) are a class of MRSA causing infections in 
communities, where patients have not been exposed to classical risk factors, meaning that 
these organisms were not acquired in the hospital (2). This class appeared more recently 
and was found to carry several enterotoxins and PVL, which are probably responsible for the 
high mortality rate in previously healthy persons (2, 133). 
 
Glycopeptides, such as vancomycin and teicoplanin, comprise another group of antibiotics 
acting on cell wall synthesis, and play a key role in the treatment of MRSA. As β-lactams, 
they block transpeptidases, but by a different mechanism. By binding to the D-alanyl-D-
alanine of the stem peptide, they block the substrate and prevent it from reacting with 
transpeptidases or transglycosylases. However, first cases of glycopeptide-intermediate 
resistant S. aureus strains were reported in 1996 and soon afterwards, the first vancomycin-
resistant S. aureus (VRSA) strains appeared (56). Vancomycin-resistant S. aureus (VRSA) 
strains carry the vanA gene cluster, which was most probably acquired by horizontal gene 
transfer from Enterococci (24). VanA enables the bacterium to produce altered peptidoglycan 
pentapeptide precursors. Instead of the terminal D-alanyl-D-alanine, they produce D-alanyl-
D-lactate, which leads to a decreased binding affinity for glycopeptides (24). The resistance-
mechanisms of glycopeptide-intermediate S. aureus (GISA) are not clearly understood, yet. 
However, at least two or more mutations are required for intermediate resistance. GISA 
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strains have usually a thickened cell wall, and contain more D-alanyl-D-alanine in the 
peptidoglycan due to reduced cross-linking (146).  
The rapid emergence of resistance to antibiotics requires an acute awareness of physicians. 
Only a few classes of novel antibiotics have been introduced in the past 40 years. Therefore 
it is important to avoid the unnecessary use of antibiotics, which might further select for 
resistant bacteria (53).   
1.1.3 Global regulators 
S. aureus virulence and resistance are tightly controlled. Regulation takes mostly place at the 
transcriptional level due to changes in environmental factors such as bacterial density, the 
presence of antibiotics, pH or CO2. Each of these factors activate different regulatory 
systems, which constitute numerous complex networks.  
 
Two-component systems 
Two-component regulatory systems (TCS) consist of a sensor histidine kinase and a 
response regulator protein. They are very sensitive to environmental signals because the 
sensor either directly binds to a specific extracellular ligand or is associated with a receptor. 
Upon binding, autophosphorylation of the sensor kinase occurs, meaning that a phosphate 
residue of an ATP is transferred to the cytoplasmic domain of the sensor kinase. The 
phosphate is then transferred to the response regulator and the phosphorylation cascade 
finally ends with the binding of the response regulator to specific DNA sequences, which 
leads to changes in transcription (16). 
 
Probably the most extensively studied two-component system of S. aureus is the accessory 
gene regulator agr (37, 105). Quorum sensing via the agr-system has been assigned a 
central role in the pathogenesis of S. aureus. The gene products of the agr locus allow the 
bacteria to determine the actual density of a population and to regulate the transcription of a 
wide range of genes in response to this density. The actual effector is a RNA molecule, 
RNAIII, which affects virulence gene expression. The agr locus is composed of two divergent 
transcripts, RNAII and RNAIII which are under the control of the promoters P2 and P3, 
respectively. In an early growth phase, the expression of RNAII is induced through the global 
regulator SarA. RNAII encodes AgrB, D, C and A. The signal molecule AgrD is processed 
and secreted by the transporter AgrB and thereby becomes the so-called auto-inducing 
protein (AIP). With increasing density of the population, the signal molecule accumulates in 
the environment and is therefore more likely to bind to the receptor protein AgrC. This 
binding leads to phophorylation of AgrC which then activates the signal transducer AgrA. 
When phosphorylated, AgrA binds to the P2 and P3 promoters and stimulates massive 
transcription of RNAII and RNAIII. This leads to more accumulation of the signal molecule on 
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the one hand, and to a regulation of many virulence factors through the effector molecule 
RNAIII on the other hand (16) (Fig. 3). In addition to the autoinducing protein AIP, RNAII is 
also induced by RAP (RNAIII-activating protein) (5). RAP activates phosphorylation of a 21-
kDA protein, which is called TRAP (target of RAP). AIP and TRAP were suggested to 
activate RNAIII synthesis via distinct signal transduction pathways (5). Another protein called 
SvrA was first postulated to be required in the TRAP pathway (47). However, more recently, 
Chen and Novick (21) demonstrated that SvrA was not involved in agr attenuation but played 
a role in S. aureus infections via an agr-independent way. 
 
Figure 3: Quorum sensing over the agr-
system. In an early growth phase, the 
transcription of RNAII, which encodes 
AgrACDB, is stimulated. The signal 
molecule AgrD is secreted and 
processed by the transporter AgrB, 
yielding the signal molecule AIP (auto 
inducing protein). When AIP accumulates 
in the environment, it binds more 
frequently to the receptor protein AgrC, 
which then phosphorylates the signal 
transducer AgrA. The activated AgrA 
binds to the promoters P2 and P3 and 
stimulates transcription of RNAII and 
RNAIII. This leads to more accumulation 
of AIP and to regulation of many genes 
through the effector molecule RNAIII 
(adapted from (16)). 
 
 
Another important two-component system is the S. aureus exoprotein expression locus 
(sae). It is constituted of two co-transcribed genes, saeR coding for the response regulator 
and saeS, coding for the sensor protein. It was shown to regulate among others the 
transcription of hla, hlb and coa (48). Coa codes for coagulase, which belongs to the 
MSCRAMM family and converts fibrinogen to fibrin. 
The staphylococcal respiratory response (ssrAB or srhSR) locus regulates gene 
expression in response to oxygen conditions (131). This is important, because S. aureus as 
a facultative anaerobe organism has different growth characteristics depending on the 
respective oxygen pressure, and some virulence factors need oxygen for their expression 
(98). The locus codes for the response regulator protein SrrA (SrhS) and the histidine kinase 
SrrB (SrhR). The system regulates proteins of the energy metabolism but also virulence 
factors such as TSST. 
VraSR mediates response to inhibitors of early and late steps in cell wall 
peptidoglycan biosynthesis. The VraRS system coordinates the expression of more than 40 
genes in S. aureus in response to exposure to inhibitory concentrations of cell wall-active 
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antibiotics, such as glycopeptides and β-lactams. This group of genes is also called the cell 
wall stress stimulon (8).  
The autolysis-related locus regulator/sensor protein ArlRS is a repressor of biofilm 
formation and influences autolysis. It is also involved in the regulation of spa and hla, which 
is probably a result of the regulation of the sarA locus by ArlRS (44, 45). ArlRS may also 
regulate sarR, and the σB operon and it down-regulates RNAII transcription, which in turn 
leads to a decreased RNAIII transcription resulting in downregulation of several virulence 
genes. 
The two-component-system LytRS is involved in autolysis, by positively regulating the 
expression of lrgA and lrgB, which are located directly down-stream of lytS and lytR. LrgA 
and LrgB modulate the extracellular activity of murein hydrolases and also tolerance to 
penicillin  (18, 51).  
WalKR (also YycFG) is an essential two-component system. When down-regulated, cell 
permeability and susceptibility against macrolide-lincosamide-streptogramin B (MLSB) 
antibiotics is increased (83).  WalKR positively controls activity of the two major S. aureus 
autolysins, AtlA and LytM, leading to higher autolytic activity (35). WalKR was also shown to 
directly bind to the promoters of isaA and ssaA, which encode the immunodominant 
staphylococcal antigen IsaA, a putative autolysin, and the secreted antigen SsaA, 
respectively (36). Decreased peptidoglycan biosynthesis and turnover was found when 
WalKR levels were lowered. WalKR positively controls biofilm formation and was found to 
play a central role in cell wall metabolism (35). 
 
The staphylococcal accessory regulator SarA and its homologues 
The SarA protein is a DNA-binding protein, which was initially described as an activator of 
the agr operon, increasing the levels of RNAII and RNAIII and thereby altering the 
expression of virulence factors (22). Later on, it was shown to alter the expression of several 
cell wall-associated proteins and exoproteins by directly binding to their promoter regions 
(37). 
The sarA operon consists of three overlapping transcripts (sarP1, sarP3 and sarP2), which 
have a common 3’ end and are controlled by three different promoters (6). Transcription of 
sarP1 and sarP2 is initiated by the σA-specific promoters P1 and P2, while the P3 promoter is 
dependent on the stress response sigma factor σB. All three transcripts encode SarA. 
Because the expression is dependent on different sigma-factors, expression of sarA is 
allowed during all growth phases: sarP1 and sarP2 from early- to mid-exponential growth 
phase and sarP3 in the late-exponential and stationary growth-phase or during stress (82). 
There are several sarA homologues in the S. aureus genome. They posses a high level of 
similarity with SarA and are all regulatory DNA-binding proteins (46). These homologues 
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include SarR, which regulates sarA expression (82), SarH1 (SarS), which binds to the 
promoter regions of and regulates hld, ssp, hla and spa (23, 129) and SarT and SarU, which 
interact with each other and also with agr (118). The repressor of toxin, Rot, was shown to 
upregulate 86 and downregulate 60 genes (116). Other homologues identified are SarY, 
SarV and SarX (16), but they have not been well characterized, yet. 
 
Alternative sigma factors 
The association of the sigma factor with the RNA polymerase (RNAP), forming the 
holoenzyme, leads to transcription initiation. The sigma factor recognizes specific promoter 
regions. σA is required for the expression of housekeeping genes, while σB is involved in the 
regulation of the gene expression under stress conditions such as starvation and heat shock. 
σB activity itself is regulated by rsbU, -V and –W gene products. It regulates 251 genes in S. 
aureus (12). Among the regulated genes are sarA and agr. σB increases sar expression while 
simultaneously reducing the RNAIII level in a growth phase-dependent manner (13). Another 
alternative sigma-factor identified in S. aureus is a homologue of the B. subtilis σH, which is 
involved in genetic competence in the latter bacterium (93). In S. aureus, an over-expression 
of σH induced the transcription of putative genetic competence genes in two operons, i.e. 
comG and comE operons (93). 
1.1.4 Biofilms 
A biofilm is a sessile community of bacteria that is attached to an artificial or natural surface 
(34). The capacity of S. aureus to form a biofilm is an important virulence factor because it 
can lead to device-related infections. Embedment in a polymeric matrix protects bacteria 
from host defences (8), and the altered gene expression of the sessile form renders them 
refractory to antibiotic treatment (110). The majority of biofilm-mediated device-related 
infections are caused by either S. epidermidis or S. aureus (97). Implants such as catheters 
or heart valves, bear the risk of being colonized with hospital-acquired, multi-resistant 
organisms. In addition, patients that need foreign devices are mostly compromised by 
disease or trauma.  
Biofilms are formed in multiple steps: attachment of the cells to a surface, also called primary 
adherence, intercellular accumulation, glycocalyx formation, maturation of the biofilm and 
escape of the bacteria from the biofilm (50) (Fig. 4). 
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Figure 4: Model of biofilm development. Individual planktonic cells adhere to a surface and can form 
cell-to-cell-contacts. Slime is produced and the biofilm further maturates. Cells in the biofilm can return 
to a planktonic lifestyle and complete the cycle of biofilm development (adapted from (100)). 
 
The genetic and molecular basis of biofilm formation is very complex and depends on many 
factors (reviewed in (96)). Proteins which were shown to be involved in primary adherence 
include the autolysin Atl (54), the biofilm associated protein Bap (74), the surface protein 
SasG (26), and other surface-associated adhesins called MSCRAMMS (microbial surface 
components recognizing adhesive matrix molecules) (43). Teichoic acids have been 
associated with primary adherence but are at least in S. epidermidis also components of the 
biofilm glycocalyx (52, 115). Another important biofilm component is the so-called 
polysaccharide intercellular adhesin (PIA), synthesized by proteins encoded by the icaADBC 
operon. PIA was first identified in S. epidermidis, but seems to play an important role in S. 
aureus biofilm formation, as well (28). More recently, extracellular DNA (eDNA) has been 
described as another component of staphylococcal biofilms (109, 111).  
Biofilm formation is strongly affected by environmental factors (reviewed in (50, 80, 
96)). For example, the amounts of extracellular PIA and teichoic acids depend on growth 
conditions such as the medium used or on agitation (115). Anaerobiosis stimulates ica 
transcription in S. aureus (29); and growth of S. aureus during infection of a host results in 
higher PIA production than under in vitro conditions (86). Also the presence of sugars and 
salts seems to play an important role in the stimulation of biofilm formation (40, 71).  
Some global regulators have been shown to be involved in biofilm formation by S. 
aureus. An example is SarA, which was shown to be essential for biofilm formation in several 
S. aureus strains (7). Mutation of the accessory gene regulator (agr) was found to affect 
biofilm formation in some but not all S. aureus strains analyzed (99). Although the alternative 
stress sigma factor σB is important in biofilm formation in S. epidermidis, it only seems to play 
a minor role in S. aureus biofilm formation (71, 139). WalKR was shown to positively control 
autolytic activity, in particular that of the two major S. aureus autolysins, AtlA and LytM. 
Concordantly, it was demonstrated to positively control biofilm formation (35). Rbf, a member 
Primary adherence Intercellular 
accumulation
Glycocalyx
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of the AraC/XylS family was suggested to be involved in the regulation of the multicellular 
aggregation step in response to glucose or salt (76). In a wide variety of bacteria, the 
ubiquitous second messenger cyclic-di-GMP is a regulator of biofilm formation and 
maintenance (62). Interestingly, amongst a series of established and novel factors found to 
have an impact on the biofilm forming capacity of S. aureus,  inactivation of a putative protein 
with a GGDEF motif of diguanylate cyclases abolished biofilm formation in S. aureus, 
suggesting that cyclic-di-GMP may be involved staphylococcal biofilm formation as well 
(134). 
The understanding of the mechanisms which control biofilm formation in S. aureus is crucial 
to combat this pathogen. Treatments that inhibit the transcription of biofilm controlling genes 
might be a successful strategy in inhibiting device-related infections in the future.  
1.2 Carbon catabolite repression 
A global regulatory phenomenon common in virtually all bacteria is carbon catabolite 
repression (CCR). In CCR, a carbon source in the medium represses the expression of 
certain genes and operons, whose gene products are needed for the utilization of alternative 
carbon sources (17). In parallel, genes encoding the required catabolic enzymes are usually 
expressed only if the respective substrate is present. This mechanism, which is also referred 
to as carbon catabolite activation (CCA) together with CCR enables the bacterium to use the 
most energetic carbon source available and thus guarantees the best growth rates. Both 
regulatory mechanisms are controlled at the level of enzyme activity and transcription of the 
catabolic genes/operons (128). In most documented cases of CCR, the preferred carbon 
source is glucose. One well studied exception is the lactic acid bacterium Streptococcus 
thermophilus, which prefers lactose over glucose as the primary carbon and energy source, 
presenting an adaptation to a special ecological niche (140).  
The mechanisms leading to catabolite repression may be quite diverse and have been 
extensively explored in enteric Gram-negative and low-GC Gram-positive bacteria. The 
presence of a repressing carbon source can result in lower concentrations of inducers 
specific for alternate routes of catabolism, in altered activities of specific regulators, or in the 
activation of global control proteins, such as the catabolite gene activator protein (CAP) in 
enteric bacteria or the catabolite control protein A (CcpA) in low-GC Gram-positive bacteria. 
Of these mechanisms, global regulatory circuits mediated by CAP or CcpA were in the main 
focus of interest, implicating their outstanding importance. However, many aspects of CCR 
remain to be uncovered, especially in less analyzed, but medically important bacteria, such 
as S. aureus. 
14 1 Introduction  
1.2.1 The phosphoenolpyruvate-dependent phosphotransferase system  
An important role in CCR and CCA plays the phosphoenolpyruvate(PEP)-dependent 
phosphotransferase system (PTS), which is the main carbohydrate uptake system in low-GC 
Gram-positive bacteria. The importance is indicated by the presence of fifteen sugar-specific 
PTS permeases in B. subtilis (142). According to the KEGG database (65), S. aureus 
possesses 13 such permeases. In addition to glucose, these permeases specifically 
transport sucrose, trehalose, lactose, galacitol, L-ascorbate, fructose, mannitol, mannose, 
maltose, arbutin, N-acetylglucosamine and β-glucoside.  
The PTS for glucose consists of the enzyme EI, a multidomain complex EIIABC, and the 
phosphocarrier protein HPr (Fig. 5). Especially important for sensing the physiological state 
of the cell and the regulation of its nutritional situation is HPr. It can be phosphorylated at two 
sites, histidine-15 and serine-46. The balance between HPr-His-P and HPr-Ser-P is adjusted 
as follows: PEP-dependent phosphorylation of HPr by enzyme EI yields HPr-His-P and 
pyruvate. The phosphoryl group of HPr-His-P is subsequently transferred to enzyme EIIA, 
and then to EIIB, both soluble domains of the multidomain complex EII. The glucose 
molecule is transported into the cell by the integral membrane transporter domain and at the 
same time phosphorylated by EIIB, yielding glucose-6-phosphate. When PTS substrates are 
metabolized, the level of glycolytic intermediates such as fructose-1,6-bisphosphate rises 
and stimulates HPr kinase, by the expense of an ATP or a PPi to generate HPr-Ser-P, the 
form required for CCR and CCA. Thereupon the rate of sugar import by the PTS is reduced, 
because HPr-Ser-P is not a substrate for EI and does not participate in the uptake of carbon 
sources. As soon as the level of glycolytic intermediates drops and the level of inorganic 
phosphate rises, the bifunctional HPr kinase catalyses the reverse reaction, i.e. 
dephosphorylation of HPr-Ser-P yielding HPr, which then leads to increased PTS dependent 
transport again. The phosphorylation state of HPr is thus determined by enzyme EI and HPr 
kinase. While the activity of EI responds to alterations of the PTS-phosphotransfer activity 
and the PEP-to-pyruvate ratio in the cell, the activity of the HPr depends on ATP, PPi, Pi and 
fructose-1,6-bisphosphate concentrations (32, 132).  
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Figure 5: PTS-mediated glucose uptake in the model organism B. subtilis. Enzyme EI phosphorylates 
the phospho-carrier protein HPr at its catalytic histidine residue at the expense of PEP. The 
phosphoryl group is then transferred to the multidomain complex EIIABC. The glucose molecule is 
transported into the cell and at the same time phosphorylated, yielding glucose-6-phosphate in the 
cell. Fructose-1,6-bisphosphate produced from glucose-6-phosphate activates HPr kinase, which then 
phosphorylates HPr at its regulatory serine residue at the expense of ATP or PPi (adapted from (142)). 
 
1.2.2 The catabolite control protein A (CcpA) 
The catabolite control protein A (CcpA) is a member of the LacI/GalR family of transcriptional 
regulators mediating CCR in low-GC Gram-positive bacteria (142). It functions as a 
catabolite repressor or activator. Most knowledge about CcpA comes from investigations of 
the model organism B. subtilis (79, 92, 120, 147). However, CcpA has also been studied in 
other bacteria such as Streptococcus mutans (1), group A Streptococcus (3, 123), 
Streptococcus thermophilus (140), Streptococcus pneumoniae (57), Lactococcus lactis (78, 
150), Lactobacillus casei (91), and Staphylococcus xylosus (59-61).  
 
Gene regulation by CcpA 
In B. subtilis, activation of CcpA is achieved by interaction with HPr (reviewed in (127)), and 
this activation is thus interrelated to glucose uptake by the PTS. When the amount of 
fructose-1,6-bisphosphate is increased in the cell, the phosophorylation of HPr to HPr-Ser-P 
by HPr kinase is stimulated. HPr-Ser-P then forms a complex with CcpA and increases its 
affinity for particular cis-acting DNA sequences, the so-called cre-sites (catabolite-responsive 
element) (Fig. 6). Whether the transcription of a gene is repressed or activated depends on 
the location of the cre relative to the transcriptional start site. When the cre is located 
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upstream of the -35 region, activation occurs (84, 135), location within the promoter or within 
the protein coding region might on the other hand lead to prevention of transcription initiation 
(49) or blockage of the elongation (89, 149). Several general cre consensus sequences were 
proposed for B. subtilis (84, 88, 89, 143, 148). The partially degenerated consensus was 
reported to consist of 14 to 18 base pairs and was similar in all publications. The most recent 
consensus proposed was WTGAAARCGYTTWWN (W, A or T; R, G or A; Y, T or C; N, A, T, 
G or C) (88). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6:  Model of catabolite repression and activation by CcpA in the model organism B. subtilis. In 
the presence of glucose, HPr is phosphorylated at its serine-46 residue and forms a complex with 
CcpA. The complex then binds to the cre (carbon responsive element) and thereby inhibits or induces 
transcription, depending on the location of the cre (adapted from (142)). 
 
In B. subtilis, CcpA can not only be activated by HPr-Ser-P, but also by a second 
mechanism. A closely related protein of HPr, called Crh, can also be phosphorylated by HPr 
kinase, thereupon binds to CcpA and stimulates DNA-binding. Crh (for catabolite repression 
HPr) has 45 % sequence identity to HPr. It contains an active-site serine, but no regulatory 
histidine. Therefore, it has no functionality in PTS-mediated sugar uptake and only acts in 
CCR. However, a Crh mutant still showed glucose-dependent regulation in B. subtilis and the 
function of this protein is therefore not fully understood. It has been suggested, that Crh 
might be involved in the repression of genes by metabolites other than sugars (142). 
However, although S. aureus contains homologues for HPr, and HPr kinase, no homologue 
for Crh can be found in this pathogen (32).  
CcpA can apparently also regulate gene expression in the absence of glucose, and 
consequently also in the absence of HPr-Ser-P or Crh-Ser-P (69, 70, 92). Specific inhibition 
of in vitro transcription by CcpA was promoted by the presence of NADP(H). This effect was 
not due to binding of CcpA to the cre, and therefore NADP(H) is probably not acting as a 
corepressor (69). Instead, it was proposed that CcpA directly interacts with and inhibits RNA 
polymerase, a process which is stimulated by NADP(H), independently of the redox state of 
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the cell (70). However, in B. megaterium the overall NADP(H) concentration was shown to be 
fairly constant (122). Nothing has been published about the overall NADP(H) concentration in 
S. aureus and it is not clear to which signal the interaction of NADP(H) with CcpA responds. 
 
Genes controlled by CcpA 
CcpA regulates 10 % of all B. subtilis genes, most of which encode metabolic enzymes (92) 
(Fig. 7). Glycolytic enzymes and genes of the carbon overflow metabolism are induced by 
glucose. Carbon overflow comprises the metabolization of glucose only as far as pyruvate 
and acetyl-CoA and subsequent conversion to by-products of metabolism. These by-
products are excreted into the environment and comprise lactate, acetate and acetoin in 
both, B. subtilis and S. aureus (72, 124). In this way, the cell can generate ATP without using 
the cytochrome system and maintain its redox balance in the presence of high glucose 
concentrations. Genes required for gluconeogenesis or for the complete oxidation of glucose, 
such as genes of the tricarboxylic acid cycle (TCA) cycle or respiration, are repressed (15).  
However, the role of CcpA goes far beyond the regulation of carbon metabolism, as it also 
plays a role as regulator of amino acid metabolism. This is indicated for example by the 
CcpA-dependent repression of the roc and hut genes, which are involved in the conversion 
of amino acids into alternative carbon sources (127). These alternative sources are not 
needed when glucose is present in high amounts.  
 Two compounds that are of particular importance to the cell are pyruvate and 2-
oxoglutarate. Pyruvate can be directly used for the synthesis of several amino acids. Further, 
it can be metabolized to lactate or acetoin, or it can be converted to acetyl-CoA. Acetyl-CoA 
can be either metabolized to acetate, introduced into the TCA cycle, or it can be used for the 
biosynthesis of fatty acids (127). 2-Oxoglutarate plays a role in several diverse pathways. If 
the cell obtains high amounts of glucose, glutamate, glutamine and other amino acids have 
to be generated. 2-Oxoglutarate provides the carbon skeleton for these amino acids. If there 
is no glucose in the medium, 2-oxoglutarate can be the entry point for several amino acids 
into central metabolism, which can thus be used as secondary carbon sources. Therefore, 2-
oxoglutarate is a central link for carbon and nitrogen metabolism. CcpA was shown to be 
involved in the regulation of both compounds, underlining its importance in metabolism (127).  
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Figure 7: Schematic overview of the main pathways 
of carbon metabolism subject to regulation by CcpA in 
B. subtilis. Arrows indicate upregulation, bars indicate 
downregulation by CcpA. PEP, phosphoenolypruvate 
(Adapted from (15, 127)). 
 
 
 
 
 
 
 
 
 
 
 
 
The role of CcpA in pathogenicity and antibiotic resistance 
In addition to its role in carbon and nitrogen metabolism, CcpA also seems to regulate 
several virulence factors and resistance. In group A streptococci, a ∆ccpA mutant was 
significantly less virulent in a mouse model of invasive infection. The mutant was also 
impaired in colonizing the mouse oropharynx (123). Almengor et al. (3) found, that the 
catabolite control protein CcpA influences expression of the virulence regulator Mga in group 
A streptococci. Mga is responsible for transcriptional activation of genes involved in 
adhesion, invasion, and immune evasion. A ∆ccpA mutant of Streptococcus pneumoniae 
was attenuated for nasopharyngeal colonization and lung infection in the mouse (57). 
Abranches et al. (1) reported that CcpA had an influence on the expression of traits that are 
critical for the establishment, persistence, and virulence in Streptococcus mutans. CcpA also 
seems to be essential for biofilm formation by this bacterium (144). In Streptococcus 
gordonii, inactivation of CcpA leads to reduced penicillin tolerance in vitro and in vivo (14). 
Interestingly, De Lencastre et al. (31) identified CcpA as influencing methicillin 
resistance in the S. aureus strain COL. This fact together with the observations in those 
bacteria mentioned above, make CcpA an interesting regulator to analyse in S. aureus.  
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1.2.3 Other regulators of carbon metabolism 
In addition to CcpA, several other regulators of carbon metabolism exist in Gram-positive 
bacteria and many metabolic genes are under the control of more than one regulator. Thus, 
a complex network is formed, which allows the bacterium to tightly regulate its metabolism in 
response to minor changes in the environment. Table 2 summarizes regulators of carbon 
metabolism in B. subtilis and shows their homologues in S. aureus. 
 
CodY 
CodY regulates genes of the nitrogen and carbon metabolism, but also transport and 
competence genes in B. subtilis. It is activated by high levels of GTP and branched chain 
amino acids (BCAA) in rapidly growing exponential phase cells and thereby represses or 
activates gene expression. CodY, together with CcpA, is the main regulator of carbon 
overflow in B. subtilis (127). An example for a gene which is upregulated by CodY is ackA, 
which codes for acetate kinase (124). At the same time, the transcription of acetyl-CoA-
synthetase (acsA) and aconitase of the TCA cycle (citB) are repressed by CodY (90). When 
the level of GTP and BCAAs drops, CodY loses its repressing activity and these genes are 
derepressed. This leads to the re-introduction of acetate and carbon overflow products and 
to the activation of the citric acid cycle. S. aureus possesses a homologue for CodY, which 
shares 64 % overall amino acid similarity with the B. subtilis CodY. Interestingly, the S. 
aureus CodY was recently shown to negatively regulate virulence gene expression (81). 
 
CcpN 
CcpN (YqzB) (for control catabolite protein for gluoneogenic genes) is a control protein of 
gluconeogenic genes in B. subtilis (121). It mediates CCR of gapB and pckA, two key genes 
for gluconeogenesis, by directly binding to their promoter regions and repressing their 
transcription. The presence of a CcpN homologue in S. aureus suggests that this CcpA-
independent mechanism of CCR is also present in this pathogen. 
 
CggR 
The enzymes catalysing the central parts of glycolysis of B. subtilis, but also of S. aureus are 
encoded by five genes, gapA, pgk, tpi, pgm, and eno. These genes are co-transcribed 
together with another gene, called cggR in B. subtilis, respectively gapR in S. aureus. This 
gene, the first cistron of the operon, codes for CggR (for central glycolytic genes regulator), 
and was found to repress transcription of the gapA operon in B. subtilis. Fructose-1,6-
bisphosphate, which is built in the presence of glucose, inhibits DNA-binding by CggR and 
thus glycolytic genes are transcribed (33).  
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CcpB 
CcpB, is a regulatory protein of the LacI family, which is involved in the catabolite repression 
of the gluconate (gnt) and xylose (xyl) operon in B. subtilis. It displays 30 % identity to CcpA, 
and especially the helix-turn-helix motifs of the two proteins are very similar. Chauvaux et al. 
(19) reported that the activity of CcpB seems to be dependent on the presence of HPr-Ser-P. 
However, similar sequences to those, which are important for the binding of CcpA to HPr-
Ser-P, are absent in CcpB (32), and argue against the assumption made by Chauvaux et al.. 
CcpB was reported to act in parallel with CcpA on catabolite repression but seems to be 
operative only under highly specific growth conditions (19). No homologue of CcpB was 
found in S. aureus. 
 
CcpC 
In B. subtilis, a regulator involved in the repression of TCA cycle genes, is CcpC. This LysR-
type transcriptional regulator, represses the transcription of the citrate synthase (citZ) and 
aconitase genes (citB). CcpC-activity is induced by citrate and is under the control of CcpA. 
CcpA-mediated control of CcpC is achieved by the repression of ccpC transcription on the 
one hand and by controlling the amount of citrate on the other hand (67, 68). CcpC also 
possesses autoregulatory properties. A CcpC-homologue with 34% overall identity can be 
found in S. aureus strain COL, in strain N315 this protein is truncated.  
 
 
Table 2: Main actors in carbon catabolite repression/activation in B. subtilis and S. aureus  
 B. subtilis
1 
S. aureus
2 
Main role 
CcpA BSU29740 SA1557 CCR and CCA of many metabolic 
genes 
HPr  BSU13900  SA0934  Activation of CcpA, part of PTS 
HPr Kinase BSU35000  SA0715  Phosphorylation of HPr and Crh 
Crh BSU34740 No homologue Activation of CcpA 
CcpN BSU25250 (YqzB) SA1393 CCR of gluconeogenic genes 
CggR BSU33950 SA0726 (GapR) CCR of glycolytic genes 
CcpB BSU40870 No homologue CCR of xylose and gluconate operon 
CcpC BSU14140 SACOL0731 (SA0627*) CCR of TCA genes 
CodY BSU16170 SA1098 
CCR and CCR of many genes of 
nitrogen and carbon metabolism  
1
 according to annotated B. subtilis subsp. subtilis str. 168 genome, accession nr. NC_000964.  
2
 according to annotated S. aureus subsp. aureus N315 genome, accession nr. NC_002745; COL genome, 
accession nr. NC_002951.2. 
*Truncated. 
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All these regulatory proteins allow the bacterium to quickly react to changes in the 
environment. Additional proteins, such as Tnr or RocR, both regulators of nitrogen 
metabolism, interact with CcpA- and CodY-mediated regulation and add even more 
complexity to the regulatory network (127).  
CcpA-mediated catabolite repression has been demonstrated in S. xylosus (59-61). This and 
the presence of CcpA, HPr and HPr kinase homologues suggest that CcpA acts in a similar 
way in S. aureus. Also homologues for CcpN, CcpC, CodY and CggR (GapR) are present in 
S. aureus. However, no homologues for CcpB, and Crh were found, indicating that CCR and 
CCA in S. aureus might differ from CCR and CCA in the model organism B. subtilis.  
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2 Aim of this study – Project description 
The catabolite control protein A (CcpA) is the main regulator of carbon catabolite repression 
and activation in low-GC Gram-positive bacteria. It has been extensively studied in the model 
organism Bacillus subtilis but also in other Gram-positives, such as Streptococcus 
pneumoniae or Staphylococcus xylosus. In addition to the regulation of metabolic genes, 
CcpA was found to be involved in the regulation of virulence and antibiotic resistance in 
some bacteria. Almost nothing is known about the role of CcpA in Staphylococcus aureus. 
An enhanced knowledge of the metabolism of this pathogen on the one hand and a possible 
connection to virulence on the other hand could help us to better understand and fight this 
important pathogen. To gain more knowledge about CcpA in S. aureus, the following projects 
were carried out: 
 
Project 1 – Staphylococcus aureus CcpA affects virulence determinant production and 
antibiotic resistance  
Antimicrobial Agents and Chemotherapy 2006; 50(4): 1183-1194 
CcpA was previously identified as being essential for methicillin resistance in the S. aureus 
strain COL. The aim of this study was to explore the role of CcpA in methicillin resistance in 
more detail, and to investigate its potential role in virulence. Investigations were carried out to 
compare the properties of a methicillin resistant S. aureus strain with those of its isogenic 
∆ccpA mutant. The main aspects considered were oxacillin resistance, the expression of 
several virulence factors, such as alpha-hemolysin (hla), surface protein A (spa), and RNAIII, 
the effector of the agr-locus. The impact of CcpA on capsule formation and glycopeptide 
resistance were also analysed in different genetic backgrounds. 
 
Project 2 – Staphylococcus aureus CcpA affects biofilm formation  
Infection and Immunity 2008; 76(5): 2044-2050 
S. aureus and S. epidermids are both able to adhere to biotic and abiotic surfaces, where 
they are enveloped in an amorphous slimy material. This ability to form biofilm makes S. 
aureus and S. epidermidis among the most frequently isolated pathogens in device-
associated infections. Staphylococcal biofilms have been extensively studied and 
interestingly many of the biofilm assays used in these investigations included high 
concentrations of glucose. As CcpA controls gene expression in the presence of glucose, the 
role of CcpA in S. aureus biofilm formation was investigated in this study. The capacity to 
form a biofilm was compared between a S. aureus biofilm producer and its isogenic ∆ccpA 
mutant using several methods, such as adherence assays and flow cell experiments. The 
possible impact of CcpA on several regulators, which are known to affect biofilm formation, 
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was also analysed. In addition, the impact of the ∆ccpA mutation on the formation of different 
matrix compounds was studied.  
 
Project 3 – Staphylococcus aureus CcpA controls tst expression 
Manuscript in preparation 
TSST-1, a superantigen produced by S. aureus, is the most common cause of toxic shock 
syndrome. The regulation of the tst gene, which encodes TSST-1, is very complex and is 
known to be influenced by several environmental factors. As one of these factors is glucose, 
and as CcpA is known to mediate gene regulation in the presence of glucose, this study 
focussed on the role of CcpA in tst expression. Investigations of tst transcription were carried 
out using promoter reporter gene fusion experiments and Northern blot analyses in different 
genetic backgrounds, including a ∆ccpA mutant. In addition to the transcriptional analyses, 
the effect of the ccpA inactivation was also assessed on the protein level. 
 
Project 4 – Analysis of the CcpA-regulon in Staphylococcus aureus 
Manuscript in preparation 
Several studies have investigated the CcpA transcriptome in different bacteria. These 
studies, which were mainly carried out in the model organism B. subtilis, have underlined the 
importance of CcpA in the regulation of the central metabolism. In this study, the CcpA 
transcriptome of S. aureus was analyzed for the first time. The investigation mainly focussed 
on the role of CcpA in metabolism, but also on virulence gene expression in S. aureus. 
These results were compared to those from other Gram-positive bacteria.  
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ABSTRACT 
The production of the Staphylococcus aureus toxic shock syndrome toxin TSST-1, encoded 
by the tst gene, is influenced by several regulators, and is subject to modulation by 
environmental factors such as pH, aerobiosis and glucose. We show here that the glucose-
induced repression of tst is mediated by the catabolite control protein CcpA. Computational 
analysis identified potential binding-sites for CcpA in the promoter regions of all sequenced 
tst genes. These so called catabolite responsive elements (cre) were identical, except that of 
the bovine mastitis isolate RF122, which differed by two base pairs, but was still palindromic 
to the same degree. tst-promoter reporter gene fusion assays using the tst promoter of strain 
N315 indicated that already 1 mM glucose repressed tst transcription. In a ∆ccpA 
background, no such repression could be observed, suggesting that CcpA was the mediator 
of the glucose-mediated repression. The tst genes of strains N315 and RF122, representing 
both cre-variants were cloned on a plasmid under their native promoters and introduced into 
strain Newman and its isogenic ∆ccpA mutant. Glucose strongly repressed transcription of 
both tst genes in strain Newman, whereas glucose repression was abolished in the isogenic 
∆ccpA mutant, confirming the data obtained from the reporter gene fusion assays. Glucose 
repression of both, tst transcription as well as TSST production was also confirmed in the 
TSST-1 producing RF122. In contrast, the tst encoding strain N315 was found to be a very 
poor TSST producer with a low and seemingly glucose independent tst transcription. 
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INTRODUCTION 
Toxic shock syndrome (TSS) is an acute and potentially fatal illness, which is caused by a 
group of bacterial superantigens, such as toxic shock syndrome toxin (TSST-1), 
staphylococcal enteroxins and streptococcal pyrogenic toxins. Superantigens, unlike 
conventional peptide antigens, bind to invariant regions of the major histocompatibility 
complex class II molecules at the surface of antigen-presenting cells outside of the classical 
antigen-binding groove and also to invariant regions of the T-cell receptor. This leads to 
activation of T-cells at orders of magnitude above antigen-specific activation, resulting in 
massive cytokine release, which in turn leads to capillary leakage and is believed to be 
responsible for hypotension, shock, and finally death (17). Especially in the early 1980’s, 
there was a major interest in TSS, because it was reported to be the cause of several 
staphylococcal TSS cases in otherwise healthy young women (7). This rise in TSS cases 
was associated with high-absorbency tampons and the disease was named menstrual TSS. 
Menstrual TSS is caused by TSST-1, which is produced by S. aureus and is encoded by tst, 
a gene found on several staphylococcal pathogenicity islands (SaPIs) (reviewed in (22)).  
The regulation of TSST-1 is known to be complex and several environmental conditions, 
including salt, oxygen and carbon dioxide, growth rate, temperature, glucose and pH were 
reported to modulate its production (3, 26, 28, 40). Global regulators shown to be involved in 
the regulation of TSST-1 are SarA (4, 6, 21), RNAIII of the agr system (3, 25), and SrrAB 
(39) (Fig.1). However, there is some contradiction about the role of SarA in tst expression, 
since Chan and Foster (4) described that repression of tst by SarA was agr-independent, 
while Novick (21) found that tst repression was dependent on agr. SrrAB, which is also a 
repressor of RNAIII (24), was previously shown to repress tst transcription under limited 
oxygen pressure (39). More recently, Pragman et al. (23) proposed that SrrAB, in addition to 
its downregulatory function under low-oxygen conditions, enhances the levels of tst under 
aerobic conditions. More complexness is added by the fact, that tst has autoregulatory 
functions, with TSST-1 acting as a repressor on tst transcription (35) (Fig. 1). 
 
 Figure 1: Regulation of tst transcription. Arrows 
represent upregulation, bars represent 
downregulation, dashed arrows indicate 
controversial findings, and numbers in brackets 
indicate references. ?, CcpA (this study). 
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We recently analyzed the impact of the carbon catabolite protein A (CcpA) of S. aureus on 
carbon metabolism, virulence determinant expression and biofilm formation (29, 30). CcpA 
induces or represses the transcription of genes by binding to so-called catabolite responsive 
elements (cre). These cis-acting DNA sequences, which consist of 14 to 18 base pairs, have 
been extensively studied in B. subtilis (15, 18, 19, 32, 38, 41). Whether the transcription of a 
gene is repressed or activated by CcpA depends on the location of the cre relative to the 
transcriptional start site. When the cre is located upstream of the -35 region activation occurs 
(34), location in the promoter or coding region region on the other hand leads to prevention 
of transcription initiation (10) or blockage of the elongation (42). Binding of CcpA to the cre-
sites is induced by complex formation with HPr, a component of the phosphoenolpyruvate-
dependent phosphotransferase transport system (37). In the presence of glucose or other 
rapidly metabolized carbon sources, HPr is phosphorylated on serine-46, promoting it to bind 
to CcpA. But CcpA can apparently also regulate gene expression without binding to cre-sites 
(11, 12, 20). It was proposed that CcpA can directly interact with and inhibit RNA 
polymerase, a process that is stimulated by NADP or NADPH, independently of the redox 
state of the cell (12). 
Since TSST-1 production was shown to be repressed by glucose (28), and as the tst 
promoter region contained a cre-site, we investigated whether CcpA was the mediator of this 
regulatory phenomenon. We therefore analyzed the effect of glucose on tst transcription and 
TSST-1 production and compared it to the effect in a ccpA null mutant. Our results suggest 
that repression of tst by glucose is directly mediated by the carbon catabolite protein CcpA. 
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MATERIALS AND METHODS 
Bacterial strains, plasmids, and culture conditions. The bacterial strains, relevant 
phenotypes and plasmids used in this study are listed in Table 1. All strains generated for 
this study were confirmed by pulsed field gel electrophoresis of total genome SmaI digests 
(36) and by Southern blot analysis according to standard protocols using a CcpA-specific 
DIG-probe which was generated using primers previously published (30). S. aureus was 
routinely grown in Luria-Bertani (LB) medium buffered with 50 mM HEPES (pH 7.5) with a 
flask volume/culture volume ratio of 5:1 at 37°C and 200 rpm. Media were supplemented with 
50 µg ml-1 kanamycin, if appropriate. 
 
Table 1: Strains and plasmids used in this study 
 Relevant genotype and phenotype Source or reference 
S. aureus    
RN4220 NCTC8325-4 r
-
 m
+
 (restriction minus, modification plus) (13) 
Newman ATCC25904; clinical isolate, CP5 producer (8) 
MST14 Newman ccpA::tet(L), Tc
r
 (30) 
N315 Multiresistant clinical MRSA isolate, TSST-1-producer (14) 
RF122 Wild type strain from bovine mastitis, TSST-1-producer (9) 
KS87 Newman pSKA12 (tstpN315::luc
+
), Kan
r
 This study 
KS64 Newman ccpA::tet(L) pSKA12 (tstpN315::luc
+
), Tc
r
, Kan
r
 This study 
KS179 Newman pSKA20 (tstN315
+
), Kan
r
 This study 
KS180 MST14 pSKA20 (tstN315
+
), Tc
r
, Kan
r
 This study 
KS181 Newman pSKA21 (tstRF122
+
), Kan
r
 This study 
KS182 MST14 pSKA21 (tstRF122
+
), Tc
r
, Kan
r
 This study 
E. coli   
DH5α Restriction-negative strain for cloning Invitrogen 
   
Plasmids   
pSPluc+ Luciferase fusion plasmid, ColE1 replication origin, Ap
r
 Promega 
pCN34 E. coli - S. aureus shuttle plasmid, ColE1 replication 
origin and pT181 cop-wt repC, Amp
r
,
 
Kan
r
 
(5) 
pAW17 E. coli - S. aureus shuttle plasmid, ColE1 and pAMα1 
replication origins, Kan
r
 
(27) 
pSKA12 pCN34 containing a 2.5-kb tstpN315::luc
+
 fusion, Ap
r
, Kan
r
 This study 
pSKA20 pAW17 with a 1-kb PCR fragment covering tst of strain 
N315 and its proposed promoter, Kan
r
 
This study 
pSKA21 pAW17 with a 1-kb PCR fragment covering tst of strain 
RF122 and its proposed promoter, Kan
r
 
This study 
Abbreviations are as follows: Tc
r
, tetracycline resistant; Kan
r
, kanamycin resistant; Ap
r
, ampicillin 
resistant. 
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Construction of plasmid tstpN315::luc+-pCN34 (pSKA12). A 0.8 kb fragment containing the 
tst promoter region was amplified by PCR from chromosomal DNA of S. aureus N315 by the 
use of primers TstPAsp718+ (GCGCCATGGTTAATTCTCCTTCATTCAAA) including an 
Asp718 linker (underlined) and TstPNcoI- (GCGGGTACCTTCGAGAGGCAGATTACTCC) 
including a NcoI linker (underlined). The PCR product was cloned in front of the luciferase 
gene of plasmid pSPluc+. Therefrom, a 2.4 kb Asp718-EcoRI fragment, including the tst 
promoter region fused to the luciferase coding region, was cloned into plasmid pCN34, 
generating plasmid pSKA12. The identity of the construct was confirmed by sequence 
analysis and comparison to the respective N315 sequence of the NCBI database. The 
plasmid was electroporated into RN4220 and subsequently transduced into strain Newman 
and its isogenic ∆ccpA mutant (MST14), generating strains KS87 and KS64, respectively.  
 
Construction of plasmids tstN315-pAW17 (pSKA20) and tstRF122-pAW17 (pSKA21).  1-kb 
fragments containing the tst genes and promoter regions were amplified by PCR from 
chromosomal DNA of S. aureus N315 and RF122 using primers TstXbaI+ 
(GTTGTCTAGAACTCACACTTTGTTTTTTGC) including an XbaI linker (underlined) and 
TstPstI- (GTTGCTGCAGGTTTACTAATTCACCCTAGC) including a PstI linker (underlined). 
The PCR products were cloned into pAW17, generating pSKA20 and pSKA21, respectively. 
The identity of the constructs was confirmed by sequence analysis and comparison to the 
respective sequences of the NCBI database. The plasmids were electroporated into RN4220 
and subsequently transduced into strains Newman and the respective ∆ccpA mutant 
(MST14), generating strains KS179, KS180, KS181 and KS182, respectively.  
 
Luciferase assays. For glucose impulse experiments, the cultures were inoculated to an 
OD600 of 0.05 and were grown for 5 h without glucose. At 5 h, corresponding to the early 
stationary growth phase, the cultures were split and different amounts of glucose were 
added. Samples were taken at 0, 30 and 60 min after the glucose impulse. To follow the tst-
promoter-luciferase-reporter activity over time, the medium was inoculated with an overnight 
culture to an OD600 of 0.05 and the bacteria were grown for 8 h. The medium contained either 
10 mM of glucose or no glucose. Sampling was performed on an hourly basis, starting 2 h 
after inoculation. Luciferase activity was measured as described earlier, using a luciferase 
assay substrate and a Turner Designs TD-20/20 luminometer (Promega) (1). All luciferase 
assays were performed at least three times on independent experiments.  
 
Northern blot analysis. Sampling for Northern blot analysis was basically performed as for 
the glucose impulse experiments in the luciferase assays. 10 mM glucose was added to one 
half of the culture, while the other half remained without glucose. Samples were centrifuged 
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for 2 min at 12,000 x g and cell-sediments snap-frozen in liquid nitrogen. RNA isolation and 
Northern blotting were performed as described earlier (16). Primers DIGtst+ 
(TAAGCCTTTGTTGCTTGCG) and DIGtst- (CACTTTGATATGTGGATCCG) were used to 
generate digoxigenin-labeled tst probes. All Northern blot analyses were performed at least 
twice in independently isolated RNA samples. 
 
Western blot analysis. Extracellular proteins were determined from supernatants of cultures 
grown for 3 or 5 h either with or without 10 mM glucose. Supernatants corresponding to a 
final OD600 of 5 (OD600 25 for strain N315), were adjusted to the same volume for all samples 
using sterile medium. Identical amounts of BSA were added to samples as an internal control 
for semi quantitative determination of TSST-1. Proteins were precipitated with TCA at a final 
concentration of 10 %, samples were iced for 30 min, centrifuged for 15 min at 16,000 x g 
and sediments were washed twice with 5 ml acetone. After air drying, sediments were 
resuspended in 200 µl loading buffer. 10 µl of sample, corresponding to a final OD600 of 0.25 
(1.25 for strain N315) were analyzed by 10 % SDS/PAGE. Gels were either stained with 
Coomassie brilliant blue or blotted on nitrocellulose membranes. TSST-1 detection was 
performed using rabbit polyclonal anti-TSST-1 antibodies (LucernaChem, Switzerland) after 
blocking with human IgG and visualized using the SuperSignal West Pico Chemiluminescent 
Substrate (Pierce, Rockford, US). 
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RESULTS AND DISCUSSION 
The tst promoter region contains a cre. Screening strain N315 with the consensus 
sequence proposed by Miwa et al. (19), we identified a putative cre-site 22 bp upstream of 
the translational start of tst on SaPIn1 (Fig. 2A). As tst is located on different pathogenicity 
islands (SaPIs) in different strains (22), we compared the promoter regions of the tst genes 
of the published SaPIs and found identical cre-sites on SaPI1, SaPIm1, SaPIn1, and SaPI2 
(Fig. 2B). With the exception of one base pair, the cre-sites are palindromic and are located 
downstream of the transcriptional start site suggested by Vojtov et al. (35). The pathogenicity 
island SaPIbov1 of the bovine mastitis isolate RF122 had a cre-site, which differed in two 
base pairs from the cre-site of the other tst genes. However, it was still palindromic with the 
exception of one base pair (Fig. 2B). The presence of cre-sites in the different tst genes 
together with previous findings showing that glucose decreased TSST-1 production (28) 
indicated that CcpA might mediate glucose-induced tst repression. 
 
Figure 2: (A) Schematic representation of the tst promoter region of SaPIn1 (strain N315, accession 
Nr. NC_002745) showing the position of the cre-site. tst coding region, potential transcriptional start 
site and terminator are indicated. (B) Alignment of the cre-sites and their surroundings in the tst 
promoter regions of the different pathogenicity islands. Nucleotides fitting with the cre consensus of B. 
subtilis are highlighted in bold type. Inverted repeats are indicated by arrows. Differences in 
nucleotides are highlighted by grey boxes. Ambiguity codes are as follows: W denotes A or T, R 
denotes G or A, and N denotes A, C, G, or T. rbs: ribosome binding site as suggested by (2). 
 
tst expression is strongly repressed in the presence of glucose. To confirm the effect of 
glucose on the expression of tst, which has been previously described (28), we performed 
Northern blot analysis of a glucose impulse experiment. To include the two different cre-sites 
in the study, we chose strains N315 and RF122 for this purpose. As tst was known to be 
[kb] 0.5 1.510 2
tst coding sequence
cre
ATTCTATATGTAAACGTTTACACATTTGAATGAAGGAGAATTAAAA
rbs
amplified tst promoter region
2’060’203[nt] 2’062’203
SaPI1 TCTATATGTAAACGTTTACAcATTTGAATGAAGGAGAATTAAAA-ATG
SaPIm1 TCTATATGTAAACGTTTACAcATTTGAATGAAGGAGAATTAAAA-ATG
SaPIn1 TCTATATGTAAACGTTTACAcATTTGAATGAAGGAGAATTAAAA-ATG
SAPI2 TCTATATGTAAACGTTTACAcATTTGAATGAAGGAGAATTAAAA-ATG
SaPIbov1 TCTATgcGTAAACGTTTACAcATTTAAATGAAGGAGAATTAAAA-ATG
rbs
B. subtilis cre WWTGNAARCGNWWWCAWW
A
B
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expressed in early stationary growth phase (33), we cultured the cells in HEPES-buffered LB 
medium for 5 h, split the cultures and added glucose to one half.  
We found a strong tst transcription in RF122 during this growth stage and the addition of 
glucose lead to the repression of tst (Fig. 3A). Surprisingly, in strain N315, these effects were 
not seen. tst expression was much weaker, and instead of a distinct band, smears appeared. 
However, strain N315 was previously reported to have a defective RNAIII production (31), 
which might explain the low tst transcription levels. To test the impact of the genetic 
background on the expression of this gene, we fused the promoter region of the tst gene of 
strain N315 to the firefly luciferase gene, yielding tstpN315::luc
+-pCN34 (pSKA12) and 
transduced the construct into strain Newman. In the latter strain, tst promoter activity was 
strongly repressed by glucose (Fig. 3B), indicating that the lack of glucose-dependent 
repression of tst in N315 was likely to be due to the genetic background.  
To see how much glucose would be needed for repression, we performed a glucose impulse 
experiment with increasing amounts of glucose. We observed that the addition of 1 mM 
(0.018 %) glucose reduced the luciferase activity to 66 % (Fig. 3B), 2 mM (0.036 %) glucose 
decreased the activity to 35 % and concentrations of more than 4 mM to less than 20 %. This 
indicated that transcription of the tst promoter of N315 was highly sensitive to low 
concentrations of glucose.  
Figure 3: (A) tst expression in response to 
glucose in strains N315 and RF122. Cells 
were grown in HEPES-buffered LB to early 
stationary-growth phase (5 h, A600 ~ 3), 
cultures were split in half, and 10 mM glucose 
was added to one half (+ Glc) while the other 
half was left unchanged (− Glc). Samples 
were taken at 5 h (time 0), 30 and 60 min 
afterwards. Ethidium bromide-stained 23S 
rRNA patterns are shown as an indication of 
RNA loading. (B) Luciferase activity of strain 
KS87 (Newman containing a tstPN315::luc+ 
construct) in response to different glucose 
concentrations. Cells were grown in LB 
medium containing 50 mM HEPES. After 5 h, 
luciferase activity was measured, the culture 
was split and different amounts of glucose 
were added. Luciferase activity was 
measured again 1 h after the impulse. The 
average of three independent measurements 
is shown. Control: activity at 5 h, before 
glucose addition.  
 
 
Glucose-dependent repression of tst promoter activity is dependent on CcpA. To see 
whether CcpA might be necessary for the glucose-dependent repression of tst transcription, 
we transduced the tstpN315::luc
+-pCN34 construct into the ∆ccpA mutant of strain Newman 
and followed the glucose-effect over time in wild type and mutant. In the wild type, repression 
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of luciferase activity was clearly detectable already 30 min after glucose addition, and activity 
decreased further until 1 h after glucose addition (Fig. 4A). After this time point, 
measurements were discontinued, because the pH could not be kept stable any longer, and 
changes in pH are known to affect tst expression (28). In the mutant, no changes in activity 
were observed upon glucose addition, strongly suggesting that CcpA was indeed involved in 
glucose-mediated tst repression (Fig 4B). Interestingly, total activity before glucose addition 
was weaker in the wild type than in the mutant, with 35.800 (± 3.300) relative light units (rlu) 
and 52.700 (± 9.800) rlu, respectively, suggesting that CcpA exerted some regulatory 
function on tst expression even in the absence of glucose. 
 
Figure 4: (A) Relative luciferase activity of strain 
KS87 (Newman tstpN315::luc
+
) and (B) KS64 
(Newman ∆ccpA tstpN315::luc+) in a glucose 
impulse experiment. Cells were grown in LB 
medium containing 50 mM HEPES. After 5 h 
(time 0), the culture was split and 10 mM glucose 
were added to one half of the culture, (black 
bars); while the other half remained without 
glucose, (white bars). Activity at time point 0 was 
set to 100 % and relative activity after 30 and 60 
min was assessed. The average of three 
independent measurements is shown. Total 
activity at time 0: wt, 35.800 (± 3.300); mut, 
52.700 (± 9.800). 
 
 
 
To observe long-term effects of glucose on tst-promoter activity during growth, wild type and 
mutant were grown for 8 h either in the presence or absence of glucose, and luciferase 
activity was followed on an hourly basis. Without glucose, activity in the wild type started to 
raise after 3 h and reached values of around 40’000 rlu (Fig. 5A). In the presence of glucose, 
activity remained very low (300 to 600 rlu), started to rise only slowly after 5 h, when glucose 
was depleted from the medium, and finally reached a similar activity as when grown without 
glucose (Fig. 5 A). In the presence of glucose the cells grew to a higher OD600, and despite 
HEPES buffering, the pH dropped slightly after 5 h (Fig. 5B). Promoter activity in the mutant 
was about the same in the presence or absence of glucose (Fig. 5A). In the mutant, the 
difference in OD600 between cells grown in the presence or absence of glucose was smaller 
than in the wild type, and the pH remained stable up to 7 h (Fig 5B).  As seen before, 
promoter activity in the mutant was generally higher than in the wild type and rose faster 
reaching values of around 60’000 rlu.  
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Figure 5: (A) Luciferase activity and glucose consumption; and (B) growth and pH of strains KS87 
(wt), and KS64 (∆ccpA); over time. Cells were grown in LB medium containing 50 mM HEPES with 10 
mM glucose, (■); or without glucose, (▲). Data are representative for three independent 
measurements. 
 
To test whether the lack in glucose-mediated tst repression in N315 might be due to an 
impaired CcpA activity in this strain, we investigated the glucose-mediated repression of 
pckA, a gene previously reported to be under the control of CcpA (26). As in strain Newman 
and RF122, pckA expression was strongly repressed in strain N315 upon glucose addition, 
indicating that this strain possessed a functional CcpA (data not shown). 
 
The luciferase data left the question open, whether and how CcpA would repress tst 
transcription in the presence of an intact tst gene. Unfortunately, we were neither successful 
in transducing the ∆ccpA mutation into strain N315 nor RF122. We therefore introduced the 
tst genes of these two strains in trans into strain Newman and its ∆ccpA mutant. The genes 
were cloned on a plasmid and the inserts of both constructs were sequenced. tst transcripts 
were compared to transcripts of strain N315 and RF122 and were found to have identical 
sizes (1 kb) in all strains (Figure 6A). Transcription levels of the chromosomal tstRF122 of strain 
RF122 and strain Newman carrying the tstRF122 plasmid (KS181) were similar, while in the 
∆ccpA mutant (KS182) they were weaker. A strong difference in expression was observed 
between chromosomal tstN315 of strain N315, which was very week and the plasmid borne 
tstN315 carrying derivative of strain Newman (KS179), which showed a very strong expression. 
Again, tst transcription in the ∆ccpA mutant (KS180) was weaker than in the wild type, but 
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still much stronger than in the native strain N315. TSST was reported to have autoregulatory 
properties (35). Interestingly, the tst-gene in the ∆ccpA mutants showed lower transcription 
than in the corresponding wild type, while tst-promoter gene fusions lacking an intact tst gene 
exhibited higher activity in the mutant than in the wild type. This observation might be in part 
due to tst-autorepression, but it could be also due to CcpA-regulation in absence of glucose. 
Further investigations are ongoing. 
When performing glucose impulse experiments with the strains carrying the tst-plasmids, we 
found strong repression of tst expression by glucose in the parental strains, independently of 
whether they carried the N315 or the RF122 tst gene. No such effect was observed in the 
∆ccpA mutants (Fig. 6B). The fact that both tst genes were repressed by glucose in a CcpA-
dependent manner suggested that the minor difference in their cre-sites did not affect CcpA 
activity. 
 
Figure 6: (A) Comparison of size and strength 
of the tst transcripts of all TSST-1 strains used 
in this study. Samples were taken after 5 h 
growth. (B) Northern blot analysis of tst in 
strains Newman (wt) and MST14 (∆ccpA) 
carrying pSKA20 (tstN315) or pSKA21 (tstRF122). 
Cells were grown in HEPES-buffered LB to 
early stationary-growth phase (5 h, A600 ~ 3), 
cultures were split in half, and 10 mM glucose 
was added to one half (+ Glc) while the other 
half was left unchanged (− Glc). Samples were 
taken at 5 h before glucose addition (time 0), 30 
and 60 min afterwards. The expression of tstN315 
had to be adjusted in comparison to tstRF122. 
Samples were loaded as indicated. Ethidium 
bromide-stained 23S rRNA patterns are shown 
as an indication of RNA. 
 
The question remains open, why strain N315 exhibits such a weak tstN315 expression that is 
insensitive to glucose-induced stimuli, although this strain seems to possess normal CcpA 
activity. We assume that the lack of RNAIII in N315 (31), which was previously shown to be 
an important inducer of tst transcription (3, 25), may be responsible for the low level of tst 
transcription in this strain. The remaining basal tst expression in strain N315 might be either 
too low to see a CcpA-mediated repression or it might be insensitive to this type of 
regulation. As N315 also differs in terms of metabolism from the other strains by being 
unable to catabolize acetate in the post-exponential growth phase (31), this loss of 
secondary metabolite catabolism might have consequences on tst expression as well. 
Alternatively, sequence differences between strain RF122 and N315 upstream of the cloned 
promoter regions might be the reason for additional regulatory or autoregulatory effects and 
thus for the different expression levels. Also, regulatory circuits which might be present in 
strain N315, but not in the other strains could be the reason for the low tst expression in this 
strain. To answer all these questions, further investigations should be carried out.  
1.0 kb
23S RNA
A
N
3
1
5
K
S
1
7
9
K
S
1
8
0
R
F
1
2
2
K
S
1
8
1
K
S
1
8
2
tst
+ Glc
wt
1.0 kb
∆ccpA
- Glc + Glc - Glc
min
1.0 kb
23S RNA
23S RNA
0 6030 0 6030 0 6030 0 6030
tstN315
tstRF122
B
68 3 Results  
tst does not affect exoprotein patterns of strain Newman. To asses how much TSST-1 
was produced by the different strains, we analyzed supernatants of post exponential phase 
cultures. Figure 7A shows the amount of TSST-1 in the supernatant after five 5 h growth in 
all strains with strain Newman serving as negative control. Consistent with its low tst-
transcription, strain N315 produced smaller amounts of TSST-1 than the other strains. Unlike 
Vojtov and Novick (35), who found a strong difference in exoprotein pattern between TSST-
1-producing isolates and their isogenic non-TSST-1-producing derivatives, we did not 
observe significant differences in the exoprotein patterns of strain Newman and its TSST-1-
producing derivatives (Fig. 7B). Although TSST-1 gave strong signals in Western blot 
analysis, the band could not be seen on Coomassie stained gels, indicating that the TSST-1 
band might be masked by comigrating proteins or might be present at low levels. 
As we used the same forward primer as Vojtov and Novick had used to clone the tst gene, 
we can exclude, that differences in the cloned promoter region account for this discrepancy. 
However, Vojtov and Novick used the tst-gene of SaPI1, which slightly differs in the amplified 
promoter region through the lack of two thymidines 141 bp upstream of the translational start. 
Also the use of different genetic backgrounds might account for the different findings. 
 
 
Figure 7: (A) Comparison of TSST-1 amount 
after 5 h in the culture supernatants of all 
TSST-1-producing strains used in this study. 
Strain Newman served as a negative control. 
(B) Exoprotein patterns of strain Newman, 
KS179 and KS181 after 5 h growth analyzed 
by SDS/PAGE. The gel was stained with 
Coomassie brilliant blue. *, position of TSST. 
(C) Comparison of TSST-1 production in 
response to glucose in strain KS179 and 
KS180. Cells were grown for 3 h either with 
(+) or without (-) glucose and extracellular 
proteins were precipitated. BSA was added to 
the supernatant and served as control for 
equal precipitation and loading (not shown). 
KS179, Newman pSKA20 (tstN315); KS180, 
Newman ∆ccpA pSKA20 (tstN315); KS181, 
Newman pSKA21 (tstRF122); KS182, Newman 
∆ccpA pSKA21 (tstRF122). 
 
 
 
 
Glucose affects TSST-1 production in a CcpA-dependent manner. To confirm that the 
observed glucose-mediated repression of tst transcription also affected TSST-1 production,  
we determined the TSST-1 content in the supernatants of KS179  (Newman tstN315) and 
KS180 (Newman ∆ccpA tstN315) cell cultures after 3 and 5 h of growth in the presence and 
absence of 10 mM glucose. In line with the transcriptional data, we found a clear decrease in 
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TSST-1 in the supernatant of strain KS179 grown for 3 h in the presence of glucose, while 
the TSST-1 levels in the supernatants of strain KS180 were almost identical after growth for 
3 h in the presence or absence of glucose (Fig. 7C). Glucose also repressed TSST-1 
production in strain RF122 (data not shown). Surprisingly, after 5 h of growth, this effect was 
no longer observed. After this period of time, KS179 cell cultures grown in the presence or 
absence of glucose showed nearly identical TSST-1 levels in their supernatants, irrespective 
of the clear differences in tst transcription, indicating that even low levels of tst transcripts 
were apparently sufficient to lead to the accumulation of high amounts of TSST-1. Schlievert 
and Blomster (28) found strong repression of TSST-1 production using 3 % (165 mM) of 
glucose in the stationary growth phase, but not with lower glucose concentrations. However, 
this effect might also be due to a drop in pH, as they also reported that TSST-1 production 
was pH-dependent (28). 
In agreement with our transcriptional findings, strain N315 produced only low amounts of 
TSST-1 after 3 h of growth. Even at later time points, TSST-1 levels in the supernatants of 
the N315 cell cultures were still significantly lower than the TSST-1 levels found in the 
supernatants of other strains (Fig. 7A).  
 
CONCLUSION 
The expression of S. aureus virulence genes is regulated by complex networks in which 
global regulators such as the agr system and the sarA family play a central role. We recently 
showed that CcpA is also involved in the regulation of major virulence factors and regulators 
of virulence, influencing the expression of hla, spa and RNAIII. By showing that also the 
expression of tst is affected by CcpA, we add another important virulence factor to the group 
of CcpA-regulated genes/operons. Our finding that S. aureus basic metabolic processes and 
pathogenesis are intimately linked through CcpA yield enhanced knowledge of a strategy 
used by this pathogen to adapt virulence factor production to particular environmental 
conditions. 
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ABSTRACT 
CcpA is the main regulator of carbon catabolite repression and activation in low-GC Gram 
positive bacteria. Though extensively studied in other bacteria, especially in the model 
organism Bacillus subtilis, the CcpA regulon has never been investigated in the pathogen S. 
aureus. In this study, we analysed the transcriptomes of Staphylococcus aureus strain 
Newman and its ∆ccpA mutant in response to glucose during the exponential growth phase. 
By buffering the medium, secondary effects due to acidification of the medium in response to 
excretion of overflow metabolites were avoided. In the presence of glucose, CcpA was found 
to regulate genes coding for metabolism, but also for virulence determinants. More genes 
were found to be differentially expressed by CcpA in a glucose-independent manner than in 
the classical, glucose-dependent way, suggesting that glucose-independent regulation by 
CcpA might be of particular importance in S. aureus. 
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INTRODUCTION 
The catabolite control protein A (CcpA), a member of the LacI/GalR family of transcriptional 
regulators, is found in virtually all low-GC Gram-positive bacteria (70). It has been 
extensively studied in the model organism B. subtilis (10, 39, 41, 50, 73), and has been 
shown to have a similar role in controlling metabolism in other bacteria, such as 
Staphylococcus xylosus (28), Lactococcus lactis (76), Streptococcus pneumoniae (27) and 
Listeria monocytogenes (6). CcpA can either be a transcriptional repressor or activator, 
permitting the bacteria to utilize the carbon source that allows the fastest growth rate 
(reviewed in (17, 65, 67)). For activity, CcpA interacts with HPr, a component of the 
phosphoenolpyruvate-dependent phosphotransferase system (PTS), or a closely related 
protein Crh, which is missing in some low-G+C Gram-positives, such as staphylococci (17). 
In the presence of glucose or other rapidly metabolized carbon sources, these two proteins 
are phosphorylated on a specific serine residue and consequently bind independently to 
CcpA. The complex has a high affinity for the so-called catabolite responsive elements (cre) 
in B. subtilis (56). These cis-acting DNA sequences, have been extensively studied through 
mutagenesis studies (42, 46, 47, 66, 71, 74), and the consensi differ slightly from study to 
study. Whether the transcription of a gene is repressed or activated depends on the location 
of the cre relative to the transcriptional start site. When the cre is located upstream of the -35 
region, binding of the CcpA-HPr- or CcpA-Cpr-complex stimulates transcription (42, 69). 
Location of the cre within the promoter or within the protein coding region on the other hand 
leads to prevention of transcription initiation (23) or to blockage of elongation (47, 75).  
CcpA was also found to bind to cre sites in the absence of a corepressor (31-33, 50). 
Specific inhibition of in vitro transcription by CcpA was promoted by the presence of 
NADP(H). However, this effect was not due to binding of CcpA to the cre. (33) Instead, it was 
proposed that CcpA directly interacts with and inhibits RNA polymerase, a process that is 
stimulated by NADP(H), independently of the redox state of the cell. (34) In B. megaterium 
the overall NADP(H) concentration was shown to be fairly constant (60), and nothing has 
been published about the overall NADP(H) concentrations in S. aureus in response to the 
nutritional state of the cell. It is therefore not clear to which signal the interaction of NADP(H) 
with CcpA corresponds. 
In the model organism B. subtilis, CcpA was found to regulate about 10% of all genes, most 
of which encode metabolic enzymes (50). Glycolytic enzymes and genes of the carbon 
overflow pathways are induced by glucose (36, 62). In contrast, genes required for 
gluconeogenesis or for the complete oxidation of glucose, such as genes of the tricarboxylic 
acid (TCA) cycle are repressed (10). CcpA also regulates pyruvate metabolism. This 
metabolite plays an important role in central metabolism, being involved in several metabolic 
pathways (64). But the role of CcpA goes far beyond the regulation of carbon metabolism, as 
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it also plays a role in nitrogen metabolism. For example, in the presence of glucose, CcpA 
represses several genes which are necessary for the conversion of amino acids into 
alternative carbon sources. CcpA is also involved in the regulation of 2-oxoglutarate, which is 
a central link for carbon and nitrogen metabolism (64).  
In addition to its role in carbon and nitrogen metabolism, CcpA was reported to regulate the 
expression of several virulence factors and to be involved in antibiotic resistance. Thus, 
CcpA was found to be necessary for invasive infection (61) and to influence the regulation of 
genes for adhesion, invasion and immune evasion in group A Streptococcus (2). In S. 
pneumoniae, it had an influence on virulence (27), as well as in S. mutans where it 
additionally was essential for biofilm formation (1, 72). In S. gordonii, inactivation of CcpA 
lead to reduced penicillin tolerance in vitro and in vivo (9), and in S. aureus, CcpA was 
shown to influence methicillin resistance (16).  
We recently described the role of CcpA in virulence, antibiotic resistance (58) and in biofilm 
formation (57) in S. aureus. The aim of this study was to define the CcpA regulon of this 
pathogen by transcriptome analysis, mainly focussing on metabolic genes. Similar 
experiments have been carried out for other bacteria, such as B. subtilis (41, 50, 73) and L. 
lactis subsp. cremoris (76). However, the common characteristic of these analyses was that 
they were carried out in unbuffered media, leading to changes in pH which could be 
responsible for secondary effects in gene expression. Lulko et al. (41) observed the CcpA 
regulon in B. subtilis over time. But in their study, the amount of glucose varied at the 
different sampling time points, and again, changes in pH were not taken into account. To 
avoid these problems, we added the glucose during the exponential growth phase to the 
cells in a buffered medium, and sampled 30 min afterwards. At this time point the pH was not 
changed and we could exclude any secondary effects caused by pH changes. This approach 
gave us a genome wide overview of the genes subject to CcpA-control in S. aureus during 
exponential growth.  
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MATERIALS AND METHODS  
Bacterial strains and growth conditions. S. aureus Newman (20) and its isogenic ∆ccpA 
mutant MST14 (58) were grown in LB medium buffered with 50 mM HEPES (pH 7.5) in 
Erlenmeyer flasks with a culture to flask volume of 1:5 under vigorous agitation at 37°C to an 
optical density (OD600) of 1.0. One half of the culture was transferred to a new Erlenmeyer 
flask and glucose was added to a final concentration of 10 mM, while the other half remained 
without glucose. Samples for microarray analysis were taken at (OD600) of 1.0 (T0) and after 
30 minutes (T30). Total RNA was extracted as previously described (53, 54).  
Microarray design and manufacturing. The microarray was manufactured by in situ 
synthesis of 10'807 different oligonucleotide probes of 60 nucleotides length (Agilent, Palo 
Alto,CA, USA), selected as previously described (12). It covers approximately 99% of all 
ORFs annotated in strains N315 and Mu50 (37), MW2 (4) and COL (22) including their 
respective plasmids (54). Extensive experimental validation of this array has been described 
previously, using CGH, mapping of deletion, specific PCR and quantitative RT-PCR (12, 35).  
Expression microarrays. DNA-free total RNA was obtained after DNase treatment 
(Qiagen). The absence of remaining DNA traces was evaluated by quantitative PCR (SDS 
7700; Applied Biosystems, Framing-ham, MA) with assays specific for 16s rRNA (53, 54). 
Batches of 8 µg total S. aureus RNA were labelled by Cy-3 or Cy-5 dCTP using the 
SuperScript II (Invitrogen, Basel, Switzerland) following manufacturer's instructions. Labelled 
products were then purified onto QiaQuick columns (Qiagen) and mixed with 250 µl Agilent 
hybridization buffer, and then hybridized at a temperature of 60°C for 17 hours in a dedicated 
hybridization oven (Robbins Scientific, Sunnyvale, CA, USA). Slides were washed with 
Agilent proprietary buffers, dried under nitrogen flow, and scanned (Agilent, Palo Alto, CA, 
USA) using 100% PMT power for both wavelengths.  
Microarray analysis. Fluorescence intensities were extracted using the Feature extraction 
software (Agilent, version 8). Local background-subtracted signals were corrected for 
unequal dye incorporation or unequal load of labelled product. The algorithm consisted of a 
rank consistency filter and a curve fit using the default LOWESS (locally weighted linear 
regression) method. Data consisting of two independent biological experiments were 
analyzed using GeneSpring 7.3 (Agilent). An additional filter was used to exclude irrelevant 
values. Background noise of each experiment was evaluated by computing the standard 
deviation of negative control intensities. Features whose intensities were smaller than the 
standard deviation value of the negative controls in all the measurements were considered 
as inefficient hybridization and discarded from further analysis (35). Fluorescence values for 
genes mapped by 2 probes or more were averaged. Statistical significance of differentially 
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expressed genes was identified by variance analysis (ANOVA) (14, 54), performed using 
GeneSpring, including the Benjamini and Hochberg false discovery rate correction (5%). A 
gene was considered to be regulated by glucose and/or CcpA if transcription was induced or 
repressed at least two fold. 
 
Evaluation of the microarray data. Several classes of effects could be observed. Genes, 
which showed differences in total transcriptome between wild type and mutant in the 
absence of glucose at both time points, e.g. OD600 1 (T0) and after 30 min (T30), were 
considered to be CcpA-dependent, but glucose-independent. When a difference was only 
observed at one of the two time points or the gene was upregulated at one and 
downregulated at the other time point, it was assumed to have fluctuating expression 
patterns and was not considered in this study. Genes with a differential expression upon 
glucose addition in the wild type but not in the ∆ccpA mutant were considered to be strictly 
CcpA-dependent. Changes occurring in parallel in the wild type and the mutant were 
considered to be due to glucose, but CcpA-independent. A last group comprised genes, 
which were found to be affected in their expression in response to glucose in both wild type 
and mutant, but with differing ratios, or genes, which showed no regulation in the wild type, 
but regulation in the mutant upon glucose addition. This group of genes was considered to 
be partially controlled by CcpA but in an undefined way. 
For a better interpretation, the organisation of genes in putative operons was deduced from 
the transcriptional profiles of adjacent genes over time according to previous microarrays (8) 
and by searching for putative terminator sequences using TransTerm (15).  
 
Northern blot analyses. For Northern blot analysis cells were centrifuged for 2 min at 
12,000 x g and cell-sediments snap-frozen in liquid nitrogen. RNA isolation and Northern 
blotting were performed as described earlier (43). Primer-pairs are shown in Table 1. All 
Northern blot analyses were performed at least twice on independently isolated RNA 
samples. 
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Table 1:  Primers used for construction of DIG-labelled DNA probes 
Primer Sequence (5’-3’) Source or reference 
aldA+ ACAATCGAAGTGACTAATCC This study 
aldA- CGTACGATACTCATTGTGTC This study 
arg+ TGATGCAGTAATTCCAATGC This study 
arg- AATATACCTGAAGAGTCACC This study 
pflAB+ CATCTGACAATGATGATACC This study 
pflAB- GGAGTATGTTACAGATCACG This study 
rocA+ GTATTGTCTACAGTATTGCC This study 
rocA- TTAGAAGAAGCAGGATTACC This study 
rocD+ TAACTTAGGTGAATGGTACG This study 
rocD- TCTAATGCAGCAATTGATGC This study 
 
Detection of glucose and acetate  
The concentrations of glucose and acetate in the supernatants were determined using 
commercially available kits (R-Biopharm, Darmstadt, Germany) according to the 
manufacturer’s instructions.  
 
Urease assay 
McFarland 0.5-standard cell suspensions were diluted 100-fold in urea medium (13) and 
incubated in 12-well plates at 37° for 24 hours. In parallel colony forming units (cfu/ml) were 
determined. 
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RESULTS AND DISCUSSION 
To evaluate the effect of glucose and the impact of CcpA on the metabolism of S. aureus 
growing in a complex medium, we followed the differential transcriptome of exponentially 
growing cultures of strain Newman and its ∆ccpA mutant upon glucose addition. Glucose 
triggered acidification of the medium was avoided by sufficient buffering, allowing to maintain 
the pH over the time period followed.  
In line with previous findings (58), the wild type grew slightly faster than the ∆ccpA mutant, 
reaching OD600 1 approximately 20 min earlier than the mutant. The addition of glucose 
clearly increased the growth rate of the wild type, but had only a minor effect on the mutant 
(Fig. 1). 60 min after the glucose addition, almost all glucose was depleted down to 0.5 mM 
in the wild type culture. In the ∆ccpA mutant, however, glucose consumption was slower, 
with 3 mM glucose left in the medium even 60 min after the impulse (Fig. 1). The decreased 
glucose consumption rate in the ∆ccpA mutant culture might be explained by a high 
phosphorylation rate of HPr at Ser-46, similar to the situation found in B. subtilis, where the 
HPr kinase is highly active in the ∆ccpA mutant, and all HPr is phosphorylated at Ser-46. In 
this state, HPr cannot participate in sugar transport, and the PTS-mediated glucose uptake is 
largely repressed (40).  
Despite increased glucose consumption rates in the wild type, acetate production was only 
slightly enhanced compared to the mutant. A pH of 7.5 was maintained in both strains and 
under both growth conditions for over 2 h after glucose addition. Thus pH effects could be 
ruled out.  
 
 
 
 
 
 
 
 
 
Figure 1: Growth, glucose consumption and acetate formation of strain Newman (wt) and its isogenic 
∆ccpA mutant (∆ccpA). Cells were grown to OD600 1, cultures were split and 10 mM glucose were 
added to one half of the culture (squares), while the other half remained without glucose (triangles). 
Cells were sampled at OD600 1 and 30 min after the impulse for RNA isolation (indicated by arrows). 
 
Differential transcriptome analysis 
In all experiments, a gene was considered to be regulated by glucose and/or CcpA if 
transcription was induced or repressed at least two fold. The overall range of differential 
gene expression was narrow, peaking around 2-3 fold induction or repression. 
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The total number of genes, which were expressed at a sufficient level to give meaningfull 
data was 2479. 111 of these genes had no homologues in strain Newman, and where 
therefore excluded from the analysis. Of the 2368 remaining genes, a total of 159 was found 
to be regulated in a CcpA-dependent fashion upon glucose addition. 21 genes seemed to be 
partially controlled by CcpA, 12 genes exhibited CcpA-independent glucose effects. The 
largest group comprised 229 genes affected by the ∆ccpA mutation in a glucose-
independent fashion (Table 2). 
 
Table 2: Numbers of S. aureus genes subject to regulation by either glucose or CcpAa. 
Regulatory class
b
 Number of genes 
CcpA-dependent, but glucose-independent 229 
Downregulated 121 
Upregulated 108 
  
CcpA- and glucose-dependent 159 
Downregulated 80 
Upregulated 79 
  
Partially dependent on CcpA 21 
  
CcpA-independent, but glucose-dependent 12 
Downregulated 11 
Upregulated 1 
a 
A gene was considered to be regulated if transcription was induced or repressed at least two fold. 
b 
Classes partly overlap. 
 
CcpA-dependent, glucose-independent regulation 
Genes with consistent glucose-independent up- or downregulation by CcpA are listed in 
supplementary Tables 1 and 2.  
Of particular interest in this class of genes were the cap genes, which are responsible for 
capsule formation. Although their expression seemed not to be affected by glucose within the 
time span of 30 min, the wild type showed much higher expression than the ∆ccpA mutant. 
We recently reported that the presence of glucose repressed capsule formation in S. aureus 
in a CcpA-dependent manner (58). However, in that latter study we assessed capsule 
formation after 24 h growth in the presence or absence of glucose allowing indirect CcpA 
mediated glucose effects to take place. In addition, transcription of the cap operon was 
shown to be modulated by various other regulators, for example σB or the σB-dependent 
arlRS and yabJ-spoVG loci (45). 
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Genes of the urease-operon were also upregulated in the wild type compared to the ∆ccpA 
mutant, as confirmed by the increased urease production by the wild type strain in urea-
containing medium but not in the ∆ccpA mutant (Fig. 2). Urease hydrolyses urea into 
ammonia and carbon dioxide, supplying nitrogen and helping to maintain the pH stable by 
the formation of ammonium. Urease is considered to be a virulence factor contributing to 
pathogenesis in many bacteria (48).  
 
Figure 2: Urease production in urea-containing medium. The increase in 
pH resulting from the cleavage of urea is indicated by a purple colour. 
wt, strain Newman; ∆ccpA, strain Newman ∆ccpA. 
 
 
CcpA-dependent, but glucose-independent regulation has also been reported in B. subtilis 
and might indicate that CcpA does not stringently need to form a complex with HPr-Ser-P to 
exert its regulatory function (33, 50). Shelburne et al. (61) observed CcpA-DNA interaction in 
the absence of HPr-Ser-P, however, binding was much stronger in the presence of HPr-Ser-
P. Another explanation for this phenomenon was given by Kim et al. (33), who searched for 
potential effectors of CcpA by in vitro transcription in B. subtilis. They found that CcpA could 
inhibit transcription in the presence of NADP(H) without DNA binding and suggested that 
catabolite repression by CcpA could also be a result of direct interactions with the RNA 
polymerase, a process, that is enhanced by NADP(H). Nothing has been published about the 
overall NADP(H) concentrations in S. aureus cells in response to the nutritional state and 
further investigations are needed to elucidate the exact mechanism, by which CcpA 
regulates gene expression in the absence of glucose. More genes of S. aureus are subject to 
glucose-independent CcpA-mediated regulation (229 genes) than to glucose-induced CcpA-
mediated regulation (159 genes). This is in contrast to the findings in B. subtilis, in which 
glucose-dependent CcpA-regulated genes by far outweighed genes subject to glucose-
independent CcpA-regulation (50), though under different conditions. However, these 
findings suggest that glucose-independent regulation by CcpA might play a particular 
important role in S. aureus.  
 
Glucose-dependent, CcpA-dependent genes 
Supplementary Tables 3 and 4 show all genes which are subject to regulation by glucose in 
a CcpA-dependent fashion. The tables include a few genes which were not meeting the 
arbitrary threshold, such as SA0605 or SA0299. These genes were nevertheless listed 
because they are part of putative operons and showed a tendency towards regulation.  
Regulated genes were further analysed by screening for putative cre-sites using the B. 
subtilis consensus sequence (WWTGNAARCGNWWWCAWW) suggested by Miwa et al. 
2000 (47). Being aware that diverse cre-site consensi have been published (42, 46, 66, 71, 
wt ∆ccpA Medium
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74), we allowed up to two mismatches in the staphylococcal cre candidates, therewith 
allowing all putative cre consensus sequences to be identified. To constrict the cre-sites 
identified, we evaluated the presence of palindromic parts (supplementary Tables 3 and 4). 
By far not all regulated genes contained a putative cre in their vicinity, suggesting that they 
were not under direct CcpA control. An example of such indirect control is citB, which we 
recently reported to be downregulated by CcpA in the presence of glucose (57). In B. subtilis, 
citB is indirectly controlled by CcpA through the regulation of CcpC (30, 31). The presence of 
a CcpC homologue in S. aureus suggests that also in this bacterium citB might be regulated 
by CcpA over CcpC. 
For a better global understanding, the regulated genes were grouped into functional 
categories according to the KEGG database (http://www.genome.jp/kegg/) (29) (Figure 3). 
The genes belong to 11 different functional categories, with unknown proteins representing 
the largest regulated category, followed by transport/binding proteins and lipoproteins, 
metabolism of amino acids, metabolism of carbohydrates, and metabolism of nucleotides 
and nucleic acids.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Functional classification and numbers of genes that were found to be regulated by glucose 
in a CcpA-dependent way. The functional category miscelleneous contains genes of the following 
categories: adaptation to atypical conditions, DNA recombination, DNA replication, cell division, 
metabolism of phosphate, sensors, metabolism of lipids. 
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CcpA-independent regulation by glucose 
Still using the threshold of two, we assigned genes that showed similar ratios in glucose 
induced down- or upregulation in the wild type and in the mutant to a category of 
genes/operons with CcpA-independent regulation by glucose (Table 3). We found only 12 
genes fitting this category, with 11 being downregulated. Two of these genes (lacA of the lac 
operon, and SA0321 of the putative SA0318-SA0321 operon), contained a putative, but 
poorly palindromic cre-site in their promoter region.  
 
Table 3: Genes/operons with CcpA-independent regulation by glucose.  
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
Downregulated by 
glucose 
 
   
SA0256 NWMN_0200 bglA 6-phospho-beta-glucosidase  0.5 0.5 
      
SA0318 NWMN_0322 
 
ascorbate-specific PTS system 
enzyme IIC 
0.1 0.3 
SA0319 NWMN_0323  similar to PTS system component 0.2 0.2 
SA0320 NWMN_0324 
 
similar to PTS transport system IIA 
component 
0.2 0.2 
*SA0321 NWMN_0325 
 
similar to PTS multidomain 
regulator 
0.3 0.2 
      
SA1991 NWMN_2093 lacG 6-phospho-beta-galactosidase 0.5 0.5 
SA1992 NWMN_2094 lacE PTS system, lactose-specific IIBC 
component 
0.5 0.4 
SA1993 NWMN_2095 lacF PTS system, lactose-specific IIA 
component 
0.4 0.4 
SA1994 NWMN_2096 lacD tagatose-1,6-diphosphate aldolase 0.5 0.4 
SA1995 NWMN_2097 lacC tagatose-6-phosphate kinase 0.6 0.6 
SA1996 NWMN_2098 lacB galactose-6-phosphate isomerase 
LacB subunit 
0.5 0.4 
*SA1997 NWMN_2099 lacA galactose-6-phosphate isomerase 
LacA subunit 
0.6 0.5 
      
Upregulated by glucose     
SA1842 NWNM_1943 agrB accessory gene regulator B 2.0 2.5 
SAS066 NWNM_1944 agrD accessory gene regulator D 1.5 2.1 
SA1843 NWNM_1945 agrC accessory gene regulator C 1.3 1.8 
SA1844 NWNM_1946 agrA accessory gene regulator A 1.0 1.2 
a  
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (18)  and/or 
the KEGG website (29).
 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
* Genes containing cre-sites. 
 
Especially interesting in this group is the lac operon, which has been described to be under 
the control of the repressor lacR in S. aureus (51). lacR is located directly upstream of the lac 
operon. However, Oskouian and Stewart (51) proposed the existence of a second regulator 
acting as catabolite repressor in addition to lacR. In Lactobacillus casei, CcpA was shown to 
control the lac operon (49). In S. xylosus, the lac-promoter is under partial control of CcpA, 
but another, unknown mechanism was postulated to be responsible for catabolite repression 
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by glucose (5). However, in S. aureus, CcpA seems not to be involved in the regulation of the 
lac operon. Also, rapid fluctuations of the lac operon expression over growth even in the 
absence of glucose question the lac operon results (data not shown). 
 
Genes under partial control of CcpA 
Genes considered to be partially controlled by glucose in a CcpA-dependent manner are 
shown in Table 4. These genes show miscellaneous regulatory patterns. One pattern 
comprises parallel up- or downregulation by glucose in wild type and mutant, but with 
different ratios, as seen in alsDS and treP. Another set of genes (i.e. pstB or mtlF, SA1218-
1221, SA2321) show divergent glucose-regulation in wild type and mutant. A third set, 
represented by the gntPKR operon, the ribHABD operon, SA1961 and SA2434-SA2435 
changed expression in response to glucose in the mutant but not in the wild type. gntPRK 
and ribHABD contained putative cre-sites, 64 and 35 baisepairs upstream of the translational 
start of the first transcribed gene, respectively, indicating that CcpA regulates their 
expression by direct binding. In addition to control through CcpA, these genes are probably 
controlled by other regulatory proteins, as well.  
 
Table 4: Genes under partial control of CcpA1. 
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
SA0432 NWMN_0438 treP PTS system, trehalose-specific IIBC 
component  
0.5 0.2 
SA0433 NWNM_0439 treC alpha-phosphotrehalose 0.7 0.3 
SA0434 NWNM_0440 treR trehalose operon repressor 0.7 0.3 
      
SA1218 NWNM_1297 pstB phosphate ABC transporter, ATP-
binding protein (PstB) 
0.5 2.6 
SA1219 NWNM_1298  similar to phosphate ABC transporter 0.4 2.7 
SA1220 NWNM_1299  similar to phosphate ABC transporter 0.3 3.7 
SA1221 NWNM_1300 pstS thioredoxine reductase 0.1 3.6 
      
*SA1586 NWNM_1659 ribH 6,7-dimethyl-8-ribityllumazine 
synthase 
0.6 2.2 
SA1587 NWNM_1660 ribA riboflavin biosynthesis protein  0.6 1.8 
SA1588 NWNM_1661 ribB riboflavin synthase alpha chain 0.7 2.0 
SA1589 NWNM_1662 ribD riboflavin specific deaminase 0.7 2.0 
      
SA1960 NWNM_2057 mtlF PTS system, mannitol specific IIBC 
component 
6.4 0.2 
      
SA1961 NWNM_2058  similar to transcription antiterminator 
BglG family 
0.9 0.4 
      
SA2007 NWNM_2110 alsD alpha-acetolactate decarboxylase 9.1 2.7 
SA2008 NWNM_2111 alsS alpha-acetolactate synthase 9.1 3.1 
      
SA2293 NWNM_2401 gntP gluconate permease 0.7 2.5 
SA2294 NWNM_2402 gntK gluconate kinase  1.6 3.7 
*SA2295 NWNM_2403 
gntR gluconate operon transcriptional 
repressor 
1.5 3.2 
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SA2321 NWMN_2432  hypothetical protein 0.1 2.5 
      
SA2434 NWNM_2540  PTS system, fructose-specific IIABC 
component 
1.2 0.4 
SA2435 NWNM_2541 pmi mannose-6-phosphate isomerase 1.2 0.4 
1 
Genes with parallel glucose-mediated regulation in wild type and mutant but with different ratios, 
genes with divergent glucose-mediated regulation in wild type and mutant, and genes with glucose-
mediated regulation in the mutant but not in the wild type. 
a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website and/or the 
KEGG website. 
b 
Comparison of gene expression with (+) and without (-) glucose, genes with a +/- ratio of ≤ 0.5 or ≥2 
in the wild-type and the mutant were considered to be regulated). 
 
Metabolic pathways under the control of CcpA 
Glycolysis/Gluconeogenesis 
In S. aureus, glucose is mainly catabolized to pyruvate via glycolysis (11). The enzymes 
catalyzing the central parts of glycolysis of S. aureus are encoded by five genes, coding for 
glyceraldehyde-3-phosphate dehydrogenase (gap), phosphoglycerate kinase (pgk), 
triosephosphate isomerase (tpi), phosphoglyceromutase (pgm), and enolase (eno), and are 
cotranscribed in an operon. In the presence of glucose, tpi and pgk were upregulated in a 
CcpA-dependent manner (Fig. 4, supplementary table 5). The absence of putative cre-sites 
indicates indirect control by CcpA. Almost all genes of the operon showed upregulation by 
glucose in the wild type but even in the mutant, though below the threshold. This might be 
due to regulation through additional factors. A possible regulatory mechanism for these 
genes could involve gapR, which is co-transcribed with the glycolytic genes and codes for 
the glycolytic operon regulator in S. aureus. In B. subtilis, the product of this gene, also 
known as CggR (for central glycolytic genes regulator), was found to repress transcription of 
the gap orperon. Fructose-1,6-bisphosphate, which is built in the presence of glucose, 
inhibits DNA-binding by CggR and thus glycolytic genes are transcribed.  
The microarrays confirmed our previous findings (58), in which we found glucose-dependent 
and CcpA-mediated downregulation of PEP carboxykinase (pckA). The presence of a cre-
site in the promoter region (55, 58) indicates direct regulation by CcpA. This is in contrast to 
the B. subtilis pckA, which was found to be under indirect control of CcpA (10).  
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Figure 4: Assignment of genes coding for enzymes of glycolysis and gluconeogenesis which are 
regulated by CcpA. eno, enolase; fbpA, fructose-bisphosphate aldolase; fbp, fructose-1,6-
bisphosphatase; gap, glyceraldehyde-3-phosphate dehydrogenase; gapB, glyceraldehyde-3-
phosphate dehydrogenase; pckA, phosphoenolpyruvate carboxykinase; pfk, phosphofructokinase; pgi, 
glucose-6-phosphate isomerase; pgk, phosphoglycerate kinase; pgm, phosphoglycerate mutase; 
pykA, pyruvate kinase; tpi, triose-3-phosphate isomerase. *, genes with cre-sites; red, regulated 
genes. 
 
Together, these findings suggest that glycolysis/gluconeogenesis are at least partly 
controlled by CcpA in S. aureus but that most probably other regulatory mechanisms 
contribute to their regulation as well. 
  
Pentose phosphate pathway 
The pentose phosphate pathway is an alternative glucose degradation pathway of S. aureus 
(11). It provides the cell with NADPH and precursors for biomass, which are needed in many 
anabolic reactions. gntPKR was the only operon of this pathway we found to be regulated 
(Table 3). Surprisingly, these genes showed glucose-mediated upregulation in the mutant, 
but virtually no regulation in the wild type. These genes may be upregulated by glucose by a 
CcpA-independent mechanism that might be counteracted by CcpA in the wild type. In B. 
subtilis, genes of the pentose phosphate pathway were not affected by the presence of 
glucose (10), presenting a difference between B. subtilis and S. aureus CcpA-mediated 
regulation. 
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Carbon overflow 
In the presence of high glucose concentrations, many bacteria metabolize a large proportion 
of the glucose only as far as pyruvate and acetyl-CoA and the TCA cycle is down-regulated. 
Pyruvate and acetyl-CoA are then further metabolized to by-products of metabolism and 
excreted into the medium. This mechanism is referred to as carbon overflow and enables the 
cell to maintain its redox balance and to generate ATP without using the cytochrome system. 
Products of carbon overflow in S. aureus and B. subtilis include lactate, acetate and acetoin 
(36, 58, 62). When glucose is depleted from the medium, the cells reintroduce these by-
products into central metabolism.  
The genes for acetolactate synthase (alsS) and acetolactate decarboxylase (alsD), both 
involved in acetoin production, where upregulated by glucose (Table 3). Although, 
upregulation was found in wild type and ∆ccpA mutant, it was three times higher in the wild 
type, suggesting that these genes were only partially under the control of CcpA. The absence 
of a cre-site in the promoter region indicated indirect regulation. The alsSD (budBA1) operon 
has been shown to be induced under anaerobic conditions (21), indicating that our cultures 
were growing under microaerophilic conditions.  
Although the amount of acetate in the medium increased upon glucose addition in both, wild 
type and mutant (Fig.1), neither the genes coding for phosphotransacetylase (pta) nor for 
acetate kinase (ackA), both enzymes of acetate production, where significantly upregulated 
by glucose. This is in contrast to the findings in B. subtilis, in which not only alsS, but also pta 
and ackA where found to be induced by glucose in a CcpA-dependent way (26, 52, 62). 
Genes responsible for acetate and acetoin utilization such as acetyl-CoA synthetase (acsA), 
acetoin dehydrogenase (acuA), and the acetoin utilization protein (acuC) where found to be 
repressed by glucose through CcpA in B. subtilis (25). This was not the case in S. aureus.  
Formate acetyltransferase (pflA) and its activating enzyme (pflB), which are part of pyruvate 
metabolism, were found to be upregulated by CcpA in our microarrays. These data could not 
be confirmed by Northern blot analysis, where we failed to find an upregulation in the wild 
type (Fig. 5). However, as in the microarrays, transcription was much higher in the mutant 
than in the wild type, in accordance with the findings of Asunama et al. (3), who found higher 
pfl transcription in a ∆ccpA mutant of Streptococcus bovis.  
 
Figure 5: Transcription of pflAB in strain Newman and its 
∆ccpA mutant in response to glucose. Cells were grown 
to OD600 1, cultures where split and glucose added to one 
half (+), while the other half remained without glucose (-). 
RNA was sampled at OD600 1, and after 30 min. Data are 
representative for two independent experiments. 
 
Carbon overflow and pyruvate metabolism thus represent two other metabolic pathways, 
which differ in terms of CcpA-mediated regulation between S. aureus and B. subtilis. 
Newman
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∆ccpA
0 -+0 -+
pflAB 3.2
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TCA cycle 
As in B. subtilis, CcpA repressed several genes of the TCA cycle in S. aureus, including 
citBCZ, sdhB, sucCD and odhAB (Fig. 6, supplementary Table 6). The promoter region of 
citZ, which is co-transcribed with citB contains a putative cre-site (supplementary Table 1). 
Also odhAB and sucCD exhibit putative cre-sites, indicating that the TCA cycle is under 
direct control of CcpA. These findings are very similar to those in B. subtilis. 
The pdhABCD operon, coding for the pyruvate dehydrogenase complex, which links 
glycolysis to TCA cycle, was not induced by glucose or CcpA in S. aureus, in contrast to B. 
subtilis, in which pdhABCD was activated by glucose (10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Assignment of genes coding for enzymes the TCA cycle, which are regulated by CcpA. The 
genes code for the following enzymes: ackA, acetate kinase; acsA, acetyl-CoA synthetase; citB, 
aconitate hydratase; citC, citrate dehydrogenase; citG, fumarate hydratase; citZ, citrate synthase; 
mqo2, malate:quinone-oxidoreductase; odhA, 2-oxoglutarate dehydrogenase component E1; odhB, 2-
oxoglutarate dehydrogenase component E2; pckA, phosphoenolpyruvate carboxykinase; pdhABCD, 
pyruvate dehydrogenase pycA, pyruvate carboxylase; SA2155, malate:quinone-oxidoreductase; sdhA, 
succinate dehydrogenase; sucC, succinyl-CoA synthetase, beta subunit; sucD, succinyl-CoA 
synthetase, alpha subunit. *, genes with cre-sites; red, regulated genes. 
 
 
Isocitrate
Succinyl-CoASuccinate
Fumarate
L-Malate
2-Oxoglutarate
Oxaloacetate Citrate
citC
citB
citZ*
odhA*
odhB
sucC
sucD*
sdhA
sdhB
sdhC*
citG
mqo2
SA2155
Acteyl-CoA Acteyl-P Acetate
pta ackA
acsA
PyruvatePhosphoenol
pyruvate
Glycolysis/
Gluconeogenesis
pycA
1 2
1 2
1 2
1 2
pdhABCD
1 2
1 2
Down-regulation by glucose
No regulation by glucose
wild type1
mutant2
 3 Results 91 
Amino acid degradation 
S. aureus is able to use amino acids as secondary carbon sources. However, this is not 
necessary in the presence of high amounts of glucose. Accordingly, we found that many 
genes coding for enzymes of amino acid degradation were repressed by glucose in a CcpA-
dependent fashion (Fig. 7, supplementary table 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Assignment of genes coding for enzymes of amino acid degradation, which are regulated by 
CcpA. The genes code for the following enzymes: ald, alanine dehydrogenase; aldA, aldehyde 
dehydrogenase; arg, arginase; glnA, glutamine synthetase; gudB, glutamate dehydrogenase; hutH, 
histidine ammonia-lyase hutI, imidazolonepropionase; rocA, delta-1-pyrroline-5-carboxylate 
dehydrogenase; rocD, ornithine aminotransferase; SA1334, pyrroline-5-carboxylate reductase; 
SA1365, glycine dehydrogenase subunit 2; SA1366, glycine dehydrogenase subunit 1; SA1367, 
aminomethyltransferase. Only regulated genes are shown. *, genes with cre-sites. 
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Many of these genes (aldA, rocD, gudB, ald, arg, and rocA) contain a putative cre-site in their 
promoter region (supplementary Table 3) and might therefore be under the direct control of 
CcpA. Northern blot analyses, which were performed with some of these genes, confirmed 
the findings of the microarray (Fig. 8). Degradation of amino acids yields citric acid cycle 
intermediates or their precursors that can be further metabolized and used in 
gluconeogenesis. For example, arginine, glutamine, and proline can be converted into 
glutamate and subsequently into 2-oxoglutarate, which is consequently an important link 
between carbon and nitrogen metabolism (64). Glutamate dehydrogenase (gudB) catalyses 
the reaction from glutamate to 2-oxoglutarate is glutamate dehydrogenase. According to our 
Northern blots and according to previously published microarray data (8), gudB is co-
transcribed with rocD, coding for ornithine aminotransferase. The operon contains three cre-
sites (supplementary Table 3). In both, our Northern blots and the microarray, gudB and rocD 
genes were down-regulated by CcpA in the presence of glucose.  
 
 Figure 8: Transcription of rocD/gudB, aldA, arg, and 
rocA in strain Newman and its ∆ccpA mutant in 
response to glucose. Cells were grown to OD600 1, 
cultures where split and glucose added to one half (+), 
while the other half remained without glucose (-). RNA 
was sampled at OD600 1, and after 30 min. Data are 
representative for at least two independent 
experiments. 
 
 
 
 
 
 
 
The enzyme, which catalyses the inverse reaction, i.e. the conversion of glutamate to 2-
oxoglutarate, is catalyzed by glutamate synthase (gltBD). We found no CcpA-dependent 
regulation of these genes, which is in contrast to the findings in B. subtilis, in which the 
transcription of these genes is induced by glucose and requires CcpA (64). This is another 
aspect in which S. aureus and B. subtilis differ in terms of CcpA-regulation. Nevertheless, our 
findings underline the importance of CcpA in regulating amino acid degradation and in linking 
the central carbon with the amino acid metabolism. 
 
Branched-chain amino acid synthesis  
A key element that balances the distribution of pyruvate and 2-oxoglutarate is the pathway 
for the biosynthesis of branched-chain amino acids (BCAAs) (64). However, none of the 
genes devoted to BCAA biosynthesis where found to be induced by the presence of glucose 
in a CcpA dependent manner in S. aureus, which is in contrast to the findings in B. subtilis 
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(40, 63, 68). However, in a transcriptome analysis over time, Lulko et al. (41) only observed 
CcpA-mediated regulation of these genes in the late-exponential growth (transition) phase in 
B. subtilis. Thus, it is possible, that also in S. aureus these genes might be regulated by 
glucose in a CcpA-dependent manner at a later time point.  
 
Transporters and lipoproteins 
We found 29 genes coding for transporters or lipoproteins to be regulated by glucose in a 
CcpA-dependent manner or to be at least partially controlled by CcpA (Table 5). Seven of 
these genes contained putative cre-sites in their promoter region, or as in the case of 
SA0186, SA0302, and gntP, belonged to an operon which contained a putative cre-site and 
were probably under the direct control of CcpA. The upregulation of the glucose uptake 
protein homolog (SA2053) might be another reason for the rapid glucose consumption 
observed in the wild type (Fig. 1). Many non-sugar-transporters were found to be regulated 
by CcpA, such as the opu-operon, coding for an osmoprotectant transport system, or for 
transporters for ammonium, pyrimidine nucleosides or amino acids. These findings reveal 
that the role of CcpA goes beyond the regulation of central carbon metabolism.  
 
Table 5: CcpA-dependent genes coding for transport/binding proteins and lipoproteins 
regulated by glucose 
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
Downregulated by glucose   
SA0100 NWMN_0049  similar to Na+ Pi-cotransporter  0.2 1.7 
      
*SA0186 NWNM_0136  sucrose-specific PTS tranporter IIBC 
component protein  
0.4 1.2 
      
*SA0302 NWNM_0255  probable pyrimidine nucleoside 
transport protein 0.4 1.8 
      
*SA1848 NWNM_1950 nrgA probable ammonium transporter 0.4 0.8 
      
SA2226 NWNM_2337  similar to D-serine/D-alanine/glycine 
transporter 
0.2 0.9 
SA2227 NWNM_2337  amino acid ABC transporter homolog 0.1 0.9 
      
Upregulated by glucose   
SA0166 NWNM_0116  similar to nitrate transporter 2.8 1.1 
SA0167 NWNM_0117  similar to membrane lipoprotein SrpL 2.8 1.6 
SA0168 NWNM_0118  similar to probable permease of ABC 
transporter 2.3 1.1 
      
*SA0214 NWMN_0158 uhpT hexose phosphate transport protein 2.1 1.1 
      
SA0334 NWMN_0339  sec-independent protein translocase 
protein TatC 2.3 1.1 
SA0335 NWMN_0340  twin-arginine translocation protein TatA 2.2 1.4 
      
SA0374 NWNM_0379 pbuX xanthine permease 7.2 1.1 
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*SA0655 NWNM_0669 fruA fructose specific permease 2.4 1.3 
      
SA0769 NWNM_0780  D-methionine transport system ATP-
binding protein 2.4 0.8 
SA0770 NWNM_0781  D-methionine transport system 
permease 2.4 1.0 
      
SA1270 NWNM_1347  similar to amino acid permease 2.0 1.1 
      
SA2053 NWNM_2158  glucose uptake protein homolog 2.5 1.2 
      
SA2234 NWMN_2344 opuCD probable glycine 
betaine/carnitine/choline ABC 
transporter (membrane part) OpuCD 
1.6 1.2 
SA2235 NWMN_2345 opuCC glycine betaine/carnitine/choline ABC 
transporter (osmoprotection) OpuCC 
1.9 1.2 
SA2236 NWMN_2346 opuCB probable glycine 
betaine/carnitine/choline ABC 
transporter (membrane part) OpuCB 
1.9 1.1 
*SA2237 NWMN_2347 opuCA glycine betaine/carnitine/choline ABC 
transporter (ATP-binding) OpuCA 
2.6 1.0 
      
SA2239 NWNM_2349  similar to amino acid transporter  2.2 1.1 
      
SA2443 NWMN_2549  similar to accessory secretory protein 
Asp3 2.0 1.2 
SA2444 NWMN_2550  similar to accessory secretory protein 
Asp2 2.3 1.3 
      
Partially controlled by CcpA    
SA0432 NWMN_0438 treP PTS system, trehalose-specific IIBC 
component  
0.5 0.2 
      
SA1218 NWNM_1297 pstB phosphate ABC transporter, ATP-
binding protein (PstB) 
0.5 2.6 
SA1219 NWNM_1298  similar to phosphate ABC transporter 0.4 2.7 
SA1220 NWNM_1299  similar to phosphate ABC transporter 0.3 3.7 
      
SA1960 NWNM_2057 mtlF PTS system, mannitol specific IIBC 
component 
6.4 0.2 
      
*SA2293 NWNM_2401 gntP gluconate permease 0.7 2.5 
      
SA2434 NWNM_2540  PTS system, fructose-specific IIABC 
component 
1.2 0.4 
a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (18)  and/or 
the KEGG website (29). 
b
Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
*Genes containing cre-sites. 
 
Pathogenicity factors 
The microarray confirmed our previous findings, in which we observed CcpA-dependent 
downregulation of spa, coding for protein A (Table 6) (58). Also genes coding for other 
antigens, namely the immunodominant antigen A (IsaA), the staphylococcal secretory 
antigen SsaA and a homologue of SsaA, where downregulated by glucose in the wild type. 
SsaA and IsaA are both known to be under the control of WalKR (19), however, this two-
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component system was not controlled by CcpA. Atl gene, coding for the bifunctional 
autolysin, was downregulated by glucose in the wild type strain. This is partially in contrast to 
previous findings, in which we observed a trend towards stronger atl expression in glucose 
containing BHI medium in the wild type in comparison to a ∆ccpA mutant (57). However, 
growth conditions and strains differed between the two studies. 
The genes coding for the two-component-system VraSR were found to be upregulated by 
glucose in a CcpA-dependent manner. This system was reported to regulate the genes of the 
so-called cell wall stress stimulon, a set of genes that is induced in the presence of cell wall 
damaging agents (7). Indeed some of the genes, which were reported to belong to the cell 
wall stress stimulon of strain Newman (44), were found to be also regulated by glucose in a 
CcpA-dependent manner. However, there was no specific correlation between up- and 
downregulation in response to glucose and vancomycin. 
Although rsbW, coding for the anti-sigma B factor was upregulated twofold by glucose in the 
wild type in a CcpA-dependent manner, none of the other cotranscribed genes of the sigma 
B operon, i.e. rsbVU and σB (59) showed increased expression (Table 4). Also the 
transcription of asp23, a model indicator of σB activity, showed no CcpA-dependent 
regulation above the threshold under these conditions, indicating CcpA did neither influence 
σB transcription nor activity. 
Surprisingly, we found rbf, a gene involved in glucose and salt dependent biofilm formation 
(38), to be upregulated by glucose in a CcpA-dependent manner. We previously described 
the role of CcpA in biofilm formation (57) and did not find rbf regulation by CcpA under the 
conditions used in that study. However, the microarray data suggest, that CcpA-dependent 
regulation of rbf might play a role in biofilm formation only under specific conditions. 
The gene coding for the fibronectin binding protein B (fnbB), was upregulated in the wild type 
by glucose. Although this protein is truncated and not functional in strain Newman (24), it 
might be regulated by CcpA in strains where it is functional, suggesting, that CcpA may affect 
also adherence and host cell invasion.  
The microarray confirmed previously published data, that cidA transcription is higher in the 
wild type than in the ∆ccpA mutant (57). CidA, controlling cell lysis and the release of eDNA, 
was shown to contribute to biofilm formation, which is strongly induced in the presence of 
glucose (57). 
Surprisingly, agrB of the agr locus was found to be upregulated by glucose in wild type and 
mutant. However, none of the other agr-genes which are cotranscribed with agrB showed 
upregulation above threshold level.   
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Table 6: Regulators and factors involved in virulence and/or resistance and are subject to 
regulation by CcpA and/or glucose 
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
CcpA-dependent regulation    
Downregulated by glucose    
*SA0107 NWNM_0055 spa immunoglobulin G binding protein A 
precursor 
0.2 1.1 
      
SA0620 NWNM_0634  secretory antigen SsaA homologue 0.4 0.9 
      
SA0841 NWNM_0851  similar to cell surface protein Map-w 0.4 0.9 
      
SA0905 NWNM_0922 atl autolysin (N-acetylmuramyl-L-alanine 
amidase and endo-b-N-
acetylglucosaminidase)  
0.4 1.1 
      
SA2353 NWNM_2466  similar to secretory antigen precursor 
SsaA  
0.5 1.0 
      
SA2356 NWNM_2469 isaA immunodominant antigen A 0.4 0.8 
      
Upregulated by glucose    
SA0622 NWNM_0636 rbf similar to AraC/XylS family 
transcriptional regulator 
2.2 1.0 
      
SA1009 NWNM_1075  similar to exotoxin 1 2.2 0.8 
SA1010 NWNM_1076  similar to exotoxin 4 2.3 0.6 
      
SA1700 NWNM_1822 vraR two-component response regulator  2.2 0.8 
SA1701 NWNM_1823 vraS two-component sensor histidine kinase 2.5 0.7 
      
SA1869 NWNM_1970 sigB sigma factor B 1.7 1.0 
SA1870 NWNM_1971 rsbW anti-sigmaB factor 2.2 1.1 
SA1871 NWNM_1972 rsbV anti-sigmaB factor antagonist 1.3 0.9 
SA1872 NWNM_1973 rsbU sigmaB regulation protein RsbU 0.9 0.7 
     
SA2290 NWNM_2397 fnbB fibronectin-binding protein homolog 2.6 1.5 
      
*SA2329 NWNM_2440 cidA murein hydrolase regulator 3.5 1.4 
      
CcpA-independent regulation    
SA1842 NWNM_1943 agrB accessory gene regulator B 2.0 2.5 
SAS066 NWNM_1944 agrD accessory gene regulator D 1.5 2.1 
SA1843 NWNM_1945 agrC accessory gene regulator C 1.3 1.8 
SA1844 NWNM_1946 agrA accessory gene regulator A 1.0 1.2 
a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (18)  and/or 
the KEGG website (29). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
* Genes containing cre-sites. 
 
Many virulence-associated genes, such as α-hemolysin or other excreted proteins are 
expressed in later stages than exponential growth. To observe their regulation and CcpA 
dependence, further analysis at a later time points would be necessary. 
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CONCLUSION 
This study identified the CcpA regulon of exponentially growing cells in S. aureus for the first 
time. As in other bacteria, the CcpA-regulon of S. aureus comprised a large amount of 
metabolic genes but also genes associated with virulence. Although overall regulation of 
central carbon metabolism mediated by CcpA was found to be similar to the one in the model 
organism B. subtilis, the extent to which this control was exerted seemed to differ in some 
aspects between the two bacteria. In general, overall induction or repression levels of CcpA 
were low, showing mostly values around the threshold level of 2 and 0.5, respectively. 
However, inactivation of CcpA still leads to changes in metabolism and has an influence on 
resistance, virulence and biofilm formation (57, 58). One interesting outcome of this study 
concerns the genes that were regulated by CcpA even in the absence of glucose. This group 
of genes comprised even more genes than the group with glucose-dependent, CcpA-
dependent genes. This finding suggests that glucose-independent regulation by CcpA might 
be of particular importance in S. aureus and needs further investigation.  
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Supplementary Table 1: Genes with higher expression in mutant. 
ID   wt/mut wt/mut 
N315 Newman common Product
a
 T0
b
 T30
b
 
SA0107 NWMN_0055 spa immunoglobulin G binding protein A 
precursor 
0.4 0.2 
SA0108 NWMN_0056 sarH1 staphylococcal accessory regulator A 
homologue 
0.4 0.2 
SA0128 NWMN_0077 sodM superoxide dismutase 0.6 0.5 
SA0131 NWMN_0080 pnp purine nucleoside phosphorylase 0.6 0.2 
SA0143 NWMN_0094 adhE alcohol-acetaldehyde dehydrogenase 0.3 0.3 
SA0183 NWMN_0133 glcA PTS enzyme II (EC 2.7.1.69), glucose-
specific, factor IIA homologue 
0.4 0.2 
SA0213 NWMN_0157  conserved hypothetical protein 0.4 0.3 
SA0216 NWMN_0160  similar to two-component sensor histidine 
kinase 
0.5 0.4 
SA0218 NWMN_0162 pflB formate acetyltransferase 0.3 0.2 
SA0219 NWMN_0163 pflA formate acetyltransferase activating 
enzyme 
0.3 0.2 
SA0231 NWMN_0175  similar to flavohemoprotein 0.5 0.7 
SA0299 NWMN_0253  similar to carbohydrate kinase, PfkB 
family 
0.3 0.1 
SA0300 NWMN_0253  truncated hypothetical protein 0.1 0.1 
SA0301 NWMN_0254  conserved hypothetical protein 0.1 0.1 
SA0302 NWMN_0255  probable pyrimidine nucleoside transport 
protein 
0.2 0.1 
SA0304 NWMN_0257 nanA N-acetylneuraminate lyase subunit 0.7 0.3 
SA0305 NWMN_0258  similar to glucokinase 0.6 0.4 
SA0354 NWMN_0359 rpsR 30S ribosomal protein S18 0.7 0.5 
SA0374 NWMN_0379 pbuX xanthine permease 0.6 0.4 
SA0376 NWMN_0381 guaA GMP synthase (glutamine-hydrolyzing) 0.7 0.5 
SA0387 NWMN_0394 set11 exotoxin 11 (Pathogenicity island SaPIn2) 0.2 0.2 
SA0389 NWMN_0396 set13 exotoxin 13 (Pathogenicity island SaPIn2) 0.7 0.5 
SA0390 NWMN_0397 set14 exotoxin 14 (Pathogenicity island SaPIn2) 0.5 0.3 
SA0433 NWMN_0439  alpha-glucosidase 0.5 0.2 
SA0434 NWMN_0440  similar to trehalose operon transcriptional 
repressor 
0.6 0.3 
SA0452 NWMN_0457 veg VEG protein homologue 0.4 0.4 
SA0479 NWMN_0483 nupC pyrimidine nucleoside transport protein 0.7 0.5 
SA0495 NWMN_0499 rplK 50S ribosomal protein L11 0.5 0.5 
SA0496 NWMN_0500 rplA 50S ribosomal protein L1 (BL1) 0.6 0.3 
SA0497 NWMN_0501 rplJ 50S ribosomal protein L10 (BL5) 0.7 0.5 
SA0562 NWMN_0577 adh1 alcohol dehydrogenase I 0.3 0.4 
SA0576 NWMN_0591  hypothetical protein 0.5 0.4 
SA0598 NWMN_0612 pbp4 penicillin binding protein 4 0.4 0.6 
SA0642 NWMN_0656  similar to cobalamin synthesis related 
protein 
0.7 0.5 
SA0687 NWMN_0701 nrdF ribonucleoside-diphosphate reductase 
minor subunit 
0.5 0.7 
SA0769 NWMN_0780  D-methionine transport system ATP-
binding protein 
0.6 0.4 
SA0770 NWMN_0781  D-methionine transport system permease 0.6 0.4 
SA0820 NWMN_0830 glpQ glycerophosphoryl diester 
phosphodiesterase 
0.7 0.5 
SA0868 NWMN_0880 nrdE ribonucleoside-diphosphate reductase 
major subunit 
0.6 0.4 
SA0908 NWMN_0925  conserved hypothetical protein 0.6 0.5 
SA0923 NWMN_0939 purM phosphoribosylformylglycinamidine cyclo-
ligase PurM 
0.6 0.5 
SA0924 NWMN_0940 purN phosphoribosylglycinamide 
formyltransferase 
0.5 0.4 
SA0925 NWMN_0941 purH bifunctional purine biosynthesis protein 0.4 0.3 
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PurH 
SA0926 NWMN_0942 purD phosphoribosylamine--glycine ligase 
PurD 
0.7 0.5 
SA0937 NWMN_0952  cytochrome D ubiquinol oxidase subunit 1 
homolog 
0.4 0.6 
SA0938 NWMN_0953  cytochrome D ubiquinol oxidase subunit II 
homolog 
0.3 0.5 
SA1000 NWMN_1066  similar to fibrinogen-binding protein 0.4 0.7 
SA1001 NWMN_1067  hypothetical protein 0.4 0.3 
SA1009 NWMN_1075  similar to exotoxin 1 0.5 0.2 
SA1010 NWMN_1076  similar to exotoxin 4 0.3 0.1 
SA1011 NWMN_1077  similar to exotoxin 3 0.5 0.3 
SA1012 NWMN_1078 argF ornithine carbamoyltransferase 0.4 0.3 
SA1013 NWMN_1079  hypothetical protein, similar to carbamate 
kinase 
0.3 0.3 
SA1081 NWMN_1148 rpsP 30S ribosomal protein S16 0.5 0.4 
SA1099 NWMN_1166 rpsB 30S ribosomal protein S2 0.7 0.4 
SA1162 NWMN_1238  hypothetical protein 0.6 0.3 
SA1240 NWMN_1321  conserved hypothetical protein 0.6 0.5 
SA1241 NWMN_1322  similar to nitric-oxide reductase 0.6 0.5 
SA1269 NWMN_1346  Blt-like protein 0.4 0.4 
SA1270 NWMN_1347  similar to amino acid permease 0.2 0.3 
SA1271 NWMN_1348  threonine deaminase IlvA homolog 0.2 0.3 
SA1272 NWMN_1349  alanine dehydrogenase 0.1 0.2 
SA1301 NWMN_1378 ndk nucleoside diphosphate kinase 0.6 0.4 
SA1442 NWMN_1515  similar to caffeoyl-CoA O-
methyltransferase 
0.4 0.4 
SA1472 NWMN_1548  conserved hypothetical protein 0.6 0.5 
SA1473 NWMN_1549 rplU 50S ribosomal protein L21 (BL20) 0.6 0.5 
SA1493 NWMN_1563 hemD uroporphyrinogen III synthase 0.5 0.4 
SA1494 NWMN_1564 hemC porphobilinogen deaminase 0.5 0.4 
SA1495 NWMN_1565 hemX HemA concentration negative effector 
hemX 
0.6 0.5 
SA1497 NWMN_1567  conserved hypothetical protein 0.5 0.5 
SA1499 NWMN_1569 tig trigger factor (prolyl isomerase) 0.5 0.5 
SA1503 NWMN_1573 rpmI 50S ribosomal protein L35 0.3 0.4 
SA1504 NWMN_1574 infC translation initiation factor IF-3 infC 0.3 0.4 
SA1506 NWMN_1576 thrS threonyl-tRNA synthetase 1 0.2 0.3 
SA1533 NWMN_1605 ackA acetate kinase homolog 0.4 0.4 
SA1554 NWMN_1626 acsA acetyl-CoA synthetase 0.5 0.2 
SA1555 NWMN_1627 acuA acetoin dehydrogenase homolog 0.5 0.3 
SA1569 NWMN_1641  conserved hypothetical protein 0.5 0.6 
SA1585 NWMN_1658  proline dehydrohenase homolog 0.5 0.2 
SA1608 NWMN_1680 metK S-adenosylmethionine synthetase 0.5 0.3 
SA1617 NWMN_1688  hypothetical protein 0.7 0.5 
SA1649 NWMN_1722  conserved hypothetical protein 0.5 0.7 
SA1701 NWMN_1823 vraS two-component sensor histidine kinase 0.7 0.3 
SA1702 NWMN_1824  conserved hypothetical protein 0.7 0.4 
SA1710 NWMN_1832  hypothetical protein, similar to DNA 
polymerase III, alpha chain PolC type 
0.4 0.5 
SA1755 NWMN_1877  hypothetical protein  0.4 0.4 
SA1813 NWMN_1928  similar to leukocidin chain lukM precursor 0.5 0.7 
SA1847 NWMN_1949 scrR sucrose operon repressor 0.7 0.3 
SA1849 NWMN_1951  conserved hypothetical protein 0.5 0.4 
SA1929 NWMN_2031 pyrG CTP synthase 0.4 0.4 
SA1960 NWMN_2057 mtlF PTS system, mannitol specific IIBC 
component 
0.6 0.3 
SA2007 NWMN_2110 alsD similar to alpha-acetolactate 
decarboxylase 
0.2 0.5 
SA2008 NWMN_2111 alsS alpha-acetolactate synthase 0.2 0.6 
SA2022 NWMN_2125 rplQ 50S ribosomal protein L17 (BL15) (BL21) 0.7 0.3 
SA2023 NWMN_2126 rpoA DNA-directed RNA polymerase alpha 0.7 0.3 
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chain 
SA2163 NWMN_2275  hypothetical protein 0.5 0.5 
SA2168 NWMN_2280  hypothetical protein 0.6 0.5 
SA2171 NWMN_2283  hypothetical protein 0.5 0.4 
SA2172 NWMN_2284 gltT proton/sodium-glutamate symport protein 0.6 0.5 
SA2173 NWMN_2285  hypothetical protein 0.3 0.4 
SA2187 NWMN_2299 nirD assimilatory nitrite reductase 0.5 0.3 
SA2188 NWMN_2300 nirB nitrite reductase 0.5 0.4 
SA2192 NWMN_2304  hypothetical protein 0.4 0.4 
SA2201 NWMN_2312  similar to ABC transporter, permease 
protein 
0.5 0.5 
SA2202 NWMN_2313  similar to ABC transporter, periplasmic 
amino acid-binding protein 
0.5 0.5 
SA2206 NWMN_2317 sbi IgG-binding protein SBI 0.4 0.5 
SA2302 NWMN_2412  similar to ABC transporter 0.3 0.2 
SA2303 NWMN_2413  similar to membrane spanning protein 0.5 0.3 
SA2304 NWMN_2414 fbp fructose-bisphosphatase 0.6 0.3 
SA2410 NWMN_2515 nrdD anaerobic ribonucleoside-triphosphate 
reductase 
0.3 0.7 
SA2423 NWMN_2529 clfB clumping factor B 0.3 0.2 
SA2425 NWMN_2531 arcC carbamate kinase 0.4 0.6 
SA2432 NWMN_2538  conserved hypothetical protein 0.4 0.4 
SA2433 NWMN_2539  similar to transcription antiterminator 
BglG family 
0.4 0.2 
SA2434 NWMN_2540  fructose phosphotransferase system 
enzyme fruA homolog 
0.2 0.1 
SA2435 NWMN_2541 pmi mannose-6-phosphate isomerase 0.1 0.1 
SA2480 NWMN_2586 drp35 Drp35 0.7 0.1 
SA2496 NWMN_2607  hypothetical protein 0.4 0.4 
SAS052 NWMN_1613 rpsD 30S ribosomal protein S4 0.6 0.5 
SAS091 NWMN_2600  hypothetical protein 0.6 0.1 
SAS093 NWMN_2614 rpmH 50S ribosomal protein L34 0.5 0.6 
a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (18) and/or 
the KEGG website (29). 
b
 Comparison of gene expression of wild type (wt) and ∆ccpA mutant (mut) at OD600 1 (T0) and 30 min 
later (T30). Genes with a  wt/mut ratio of ≤ 0.5 or ≥2 were considered to be regulated. 
 
Supplementary Table 2: Genes with higher expression in wild type. 
ID   wt/mut wt/mut 
N315 Newman common Product
a
 T0
b
 T30
b
 
SA0084 NWMN_0029  hypothetical protein 4.4 3.1 
SA0098 NWMN_0047  similar to aminoacylase 2.0 2.4 
SA0105 NWMN_0053  hypothetical protein 2.2 1.8 
SA0144 NWMN_0095 capA capsular polysaccharide synthesis 
enzyme Cap5A 
4.5 7.0 
SA0145 NWMN_0096 capB capsular polysaccharide synthesis 
enzyme Cap5B 
4.6 6.7 
SA0146 NWMN_0097 capC capsular polysaccharide synthesis 
enzyme Cap8C 
4.5 7.5 
SA0147 NWMN_0098 capD capsular polysaccharide synthesis 
enzyme Cap5D 
3.8 7.3 
SA0148 NWMN_0099 capE capsular polysaccharide synthesis 
enzyme Cap8E 
2.6 6.2 
SA0149 NWMN_0100 capF capsular polysaccharide synthesis 
enzyme Cap5F 
2.9 7.5 
SA0150 NWMN_0101 capG capsular polysaccharide synthesis 
enzyme Cap5G 
2.8 7.8 
SA0151 NWMN_0102 capH capsular polysaccharide synthesis 
enzyme O-acetyl transferase Cap5H 
3.1 8.6 
SA0152 NWMN_0103 capI capsular polysaccharide synthesis 
enzyme Cap5I 
2.0 5.1 
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SA0153 NWMN_0104 capJ capsular polysaccharide synthesis 
enzyme Cap5J 
2.1 4.6 
SA0154 NWMN_0105 capK capsular polysaccharide synthesis 
enzyme Cap5K 
2.1 3.5 
SA0155 NWMN_0106 capL capsular polysaccharide synthesis 
enzyme Cap5L 
2.0 3.5 
SA0156 NWMN_0107 capM capsular polysaccharide synthesis 
enzyme Cap5M 
2.1 3.8 
SA0157 NWMN_0108 capN capsular polysaccharide synthesis 
enzyme Cap5N 
2.3 3.9 
SA0158 NWMN_0109 capO capsular polysaccharide synthesis 
enzyme Cap8O 
1.9 3.7 
SA0163 NWMN_0114  similar to cation-efflux system membrane 
protein CzcD 
2.5 2.4 
SA0181 NWMN_0131 entB similar to isochorismatase 2.5 3.1 
SA0182 NWMN_0132 ipdC similar to indole-3-pyruvate 
decarboxylase 
2.2 2.6 
SA0208 NWMN_0153  maltose/maltodextrin transport permease 
homologue 
2.2 2.2 
SA0209 NWMN_0154  maltose/maltodextrin transport permease 
homologue 
2.9 2.3 
SA0210 NWMN_0155 gatC similar to NADH-dependent 
dehydrogenase 
2.8 2.4 
SA0238 NWMN_0182  probable PTS galacitol-specific enzyme 
IIC component 
2.5 2.0 
SA0239 NWMN_0183  sorbitol dehydrogenase 2.9 2.3 
SA0317 NWMN_0321  similar to dihydroflavonol-4-reductase 2.8 2.4 
SA0318 NWMN_0322  similar to transport protein SgaT 8.1 2.5 
SA0326 NWMN_0330  conserved hypothetical protein 2.4 2.4 
SA0327 NWMN_0331  conserved hypothetical protein 2.0 2.3 
SA0360 NWMN_0366  conserved hypothetical protein 2.3 2.8 
SA0400 NWMN_0404 lpl2nm staphylococcal tandem lipoprotein 1.9 2.4 
SA0528 NWMN_0533  similar to hexulose-6-phosphate 
synthase 
2.3 2.7 
SA0529 NWMN_0534  conserved hypothetical protein 2.5 2.9 
SA0531 NWMN_0536 proP proline/betaine transporter homologue 1.9 2.0 
SA0534 NWMN_0539 vraB acetyl-CoA c-acetyltransferase 2.2 2.3 
SA0549 NWMN_0555 mvaK2 phosphomevalonate kinase 2.4 2.1 
SA0658 NWMN_0672  similar to plant-metabolite 
dehydrogenases 
2.1 2.1 
SA0659 NWMN_0673  similar to CsbB stress response protein 2.6 3.1 
SA0665 NWMN_0679  coenzyme PQQ synthesis homologue 2.0 1.8 
SA0666 NWMN_0680  6-pyruvoyl tetrahydrobiopterin synthase 
homologue 
2.3 2.0 
SA0721 NWMN_0734  conserved hypothetical protein 2.5 2.1 
SA0722 NWMN_0735  conserved hypothetical protein 2.1 1.9 
SA0740 NWMN_0754  hypothetical protein 2.8 2.5 
SA0741 NWMN_0755  conserved hypothetical protein 2.0 2.1 
SA0751 NWMN_0766  hypothetical protein 1.9 2.1 
SA0755 NWMN_0771  similar to general stress protein 170 3.0 4.1 
SA0760 NWMN_0776  glycine cleavage system protein H 
homologue 
1.8 2.1 
SA0768 NWMN_0778  conserved hypothetical protein 4.0 3.3 
SA0780 NWMN_0791  similar to hemolysin 3.0 2.8 
SA0781 NWMN_0792  similar to 2-nitropropane dioxygenase 3.2 2.3 
SA0802 NWMN_0811  similar to NADH dehydrogenase 1.9 2.2 
SA0830 NWMN_0840  conserved hypothetical protein 2.3 2.7 
SA0848 NWMN_0859 oppF oligopeptide transport system ATP-
binding protein OppF homologue 
2.3 1.8 
SA0849 NWMN_0860  hypothetical protein, similar to peptide 
binding protein OppA 
2.7 2.0 
SA0905 NWMN_0922 atl autolysin (N-acetylmuramyl-L-alanine 2.2 2.9 
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amidase and endo-b-N-
acetylglucosaminidase) 
SA1155 NWMN_1230  cardiolipin synthetase homolog 2.2 2.1 
SA1184 NWMN_1263 citB aconitate hydratase 2.3 2.4 
SA1218 NWMN_1297 pstB phosphate ABC transporter, ATP-binding 
protein (pstB) 
2.0 3.1 
SA1219 NWMN_1298  similar to phosphate ABC transporter 1.8 3.7 
SA1365 NWMN_1439  glycine dehydrogenase 
(decarboxylating) subunit 2 homolog 
2.1 2.7 
SA1366 NWMN_1440  glycine dehydrogenase 
(decarboxylating) subunit 1 
2.0 2.3 
SA1367 NWMN_1441  aminomethyltransferase 2.2 2.4 
SA1432 NWMN_1505  conserved hypothetical protein 6.7 4.1 
SA1433 NWMN_1506  conserved hypothetical protein 5.1 2.6 
SA1435 NWMN_1508  similar to acetyl-CoA carboxylase (biotin 
carboxyl carrier subunit), accB homolog 
3.6 2.1 
SA1436 NWMN_1509  conserved hypothetical protein 3.9 2.2 
SA1443 NWMN_1516  conserved hypothetical protein 2.1 2.5 
SA1517 NWMN_1587 citC isocitrate dehyrogenase 3.0 4.5 
SA1518 NWMN_1588 citZ citrate synthase II 3.4 3.5 
SA1528 NWMN_1600  conserved hypothetical protein 2.0 3.7 
SA1529 NWMN_1601  conserved hypothetical protein 1.9 2.0 
SA1557 NWMN_1629 ccpA catabolite control protein A 43.8 73.9 
SA1606 NWMN_1678  plant metabolite dehydrogenase 
homolog 
1.9 2.1 
SA1692 NWMN_1767  conserved hypothetical protein 2.4 2.7 
SA1733 NWMN_1855  conserved hypothetical protein 2.8 2.2 
SA1774 NWMN_1896  hypothetical protein [Bacteriophage 
phiN315] 
2.0 1.9 
SA1814 NWMN_1929  similar to succinyl-diaminopimelate 
desuccinylase 
3.2 3.4 
SA1844 NWMN_1946 agrA accessory gene regulator A 2.3 1.8 
SA1924 NWMN_2026  similar to aldehyde dehydrogenase 2.9 2.2 
SA1946 NWMN_2048  conserved hypothetical protein 2.2 2.3 
SA1981 NWMN_2080  conserved hypothetical protein 2.6 2.2 
SA2006 NWMN_2109  similar to MHC class II analog 3.7 6.2 
SA2082 NWMN_2188 ureA urease gamma subunit 2.7 3.5 
SA2083 NWMN_2189 ureB urease beta subunit 3.8 4.2 
SA2084 NWMN_2190 ureC urease alpha subunit 2.3 2.6 
SA2086 NWMN_2192 ureF urease accessory protein UreF 2.0 2.1 
SA2119 NWMN_2229  similar to dehydrogenase 2.3 2.4 
SA2125 NWMN_2235  similar to formiminoglutamase 2.6 2.8 
SA2170 NWMN_2282  similar to general stress protein 26 1.8 2.1 
SA2204 NWMN_2315  phosphoglycerate mutase, pgm homolog 2.5 1.8 
SA2220 NWMN_2331  conserved hypothetical protein 2.1 1.9 
SA2243 NWMN_2353  similar to ABC transporter (ATP-binding 
protein) 
2.0 2.1 
SA2260 NWMN_2369  similar to glucose 1-dehydrogenase 2.9 2.5 
SA2262 NWMN_2371  conserved hypothetical protein 2.8 2.8 
SA2267 NWMN_2376  hypothetical protein 2.3 2.2 
SA2309 NWMN_2419  conserved hypothetical protein 1.9 2.2 
SA2331 NWMN_2442  hypothetical protein 1.9 2.3 
SA2350 NWMN_2463  conserved hypothetical protein 2.6 1.8 
SA2366 NWMN_2479  conserved hypothetical protein 3.0 3.1 
SA2367 NWMN_2480  conserevd hypothetical protein 2.6 3.0 
SA2374 NWMN_2487  conserved hypothetical protein 1.9 2.1 
SA2479 NWMN_2585  conserved hypothetical protein 2.0 3.0 
SA2485 NWMN_2591  hypothetical protein 3.4 3.6 
SA2488 NWMN_2594  hypothetical protein 2.6 1.8 
SAS022 NWMN_0777  truncated conserved hypothetical protein 2.0 2.4 
SAS023 NWMN_0779  similar to thioredoxin 3.5 2.8 
SAS056 NWMN_1861  hypothetical protein 2.1 2.5 
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a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (18) and/or 
the KEGG website (29). 
b
 Comparison of gene expression of wild type (wt) and ∆ccpA mutant (mut) at OD600 1 (T0) and 30 min 
later (T30). Genes with a wt/mut ratio of ≤ 0.5 or ≥2 were considered to be regulated. 
 
 
 
 
 
 
 
 
 
 
 
   
Supplementary Table 3: CcpA-dependent downregulation by glucose (factor of 0.5 or lower in wild type, factor of approximately 1, but below 2 in 
the mutant) 
ID   wt mut   
N315 Newman common Product
a
 +/-
b
 +/-
b
 cre
c
 Position 
SA0008 NWMN_0007 hutH histidine ammonia-lyase 0.5 1.1   
        
SA0016 NWMN_0016 purA adenylosuccinate synthase 0.3 1.0   
        
SA0100 NWMN_0049  similar to Na+ Pi-cotransporter 0.2 1.7   
        
SA0107 NWMN_0055 spa immunoglobulin G binding protein A precursor 0.2 1.1 TATTAAACCGCTTTCATT -221 TTG 
        
SA0162 NWMN_0113 aldA aldehyde dehydrogenase homologue 0.3 1.0 AATGTAAACGCTTACTAT - 87 ATG 
        
SA0181 NWMN_0131 entB similar to isochorismatase 0.2 1.2   
SA0182 NWMN_0132 ipdC similar to indole-3-pyruvate decarboxylase 0.1 1.0 ATTGTTAGCGTTTTCAGA -81 ATG 
        
SA0184 NWMN_0134  conserved hypothetical protein 0.3 1.2 AATGTAAGCGATTACACA -46 TTG 
SA0185 NWMN_0135  similar to glucokinase regulator protein 0.2 1.2   
SA0186 NWMN_0136  similar to sucrose phosphotransferase enzyme II 0.4 1.2   
SA0187 NWMN_0137  RpiR family transcriptional regulator 0.2 1.2   
        
SA0224 NWMN_0168  3-hydroxyacyl-CoA dehydrogenase FadB homolog 0.4 1.1   
        
SA0299 NWMN_0253  similar to carbohydrate kinase, PfkB family  0.6 1.7 AATGTAAGCGTTTACAAC -76 ATG 
SA0300 NWMN_0253  truncated hypothetical protein 0.6 1.5   
SA0301 NWMN_0254  conserved hypothetical protein 0.3 1.7   
SA0302 NWMN_0255  probable pyrimidine nucleoside transport protein 0.7 1.8   
        
SA0395 NWMN_0402  similar to functionally unknown protein 0.4 0.9   
        
SA0477 NWMN_0481  conserved hypothetical protein 0.3 1.3   
SA0478 NWMN_0482  conserved hypothetical protein 0.3 1.2   
        
SA0605 NWMN_619  similar to dihydroxyacetone kinase 0.6 1.0 TATGATAGCGCATTCATT -44 ATG 
SA0606 NWMN_620  conserved hypothetical protein 0.5 1.0   
SA0607 NWMN_0621  conserved hypothetical protein 0.5 1.0   
SA0620 NWMN_0634  secretory antigen SsaA homologue 0.4 0.9   
        
   
 
SA0748 NWMN_0762  hypothetical protein 0.5 1.2   
SA0749 NWMN_0763  hypothetical protein 0.4 1.3   
        
SA0760 NWMN_0776  glycine cleavage system protein H homologue 0.3 1.0 AATGTAAGCGTTTACTAA -135 TTG 
        
SA0818 NWMN_0827 rocD ornithine aminotransferase 0.3 1.0 AATGTAAGGGTTTTCAAA - 133 ATG 
SA0819 NWMN_0828 gudB NAD-specific glutamate dehydrogenase 0.2 1.1 TTTGTAAGGGCTTTAAAA 
TTTGAAAGCGAAATCATT 
- 24 TTG 
overlaps 
TTG 
        
SA0830 NWMN_0840  conserved hypothetical protein 0.5 1.2   
        
SA0841 NWMN_0851  truncated MHC class II analog protein 0.4 0.9 AATTATAGCTTTTACATT -120 ATG 
        
SA0905 NWMN_0922 atl autolysin (N-acetylmuramyl-L-alanine amidase and 
endo-b-N-acetylglucosaminidase) 
0.4 1.1   
        
SA0915 NWMN_0932 folD FolD bifunctional protein 0.4 1.3   
        
SA1019 NWMN_1086  acetyltransferase, GNAT family protein 0.3 1.1   
        
SA1041 NWMN_1109 pyrR pyrimidine operon repressor chainA 0.4 1.1   
        
SA1088 NWMN_1155 sucC succinyl-CoA synthetase (beta subunit) 0.2 1.4   
SA1089 NWMN_1156 sucD succinyl-CoA synthetase (alpha subunit) 0.2 1.5 TACAATAGCGCTTACATT - 48 ATG 
        
SA1140 NWNM_1207 glpF glycerol uptake facilitator 1.3 0.8 ATTGACAACGCTTTCATA -116 ATG 
SA1141 NWMN_1208 glpK glycerol kinase 0.4 0.9   
        
SA1149 NWMN_1216 glnR glutamine synthetase repressor 0.4 1.2   
SA1150 NWMN_1217 glnA glutamine synthetase 0.5 1.3   
        
SA1172 NWMN_1249  guanosine monophosphate reductase 0.5 0.8   
        
SA1184 NWMN_1263 citB aconitate hydratase 0.1 1.1   
        
SA1244 NWMN_1325 odhB dihydrolipoamide succinyltransferase 0.1 1.1   
SA1245 NWNM_1326 odhA 2-oxoglutarate dehydrogenase E1 0.5 1.2 ATTGTAAGCGTTTCAACA - 19 ATG 
SA1365 NWMN_1439  glycine dehydrogenase (decarboxylating) subunit 2 0.1 1.1   
   
homolog 
SA1366 NWMN_1440  glycine dehydrogenase (decarboxylating) subunit 1 0.1 1.2   
SA1367 NWMN_1441  aminomethyltransferase 0.2 1.4   
        
SA1432 NWMN_1505  conserved hypothetical protein 0.1 1.0   
SA1433 NWMN_1506  LamB/YcsF family protein 0.1 1.1   
SA1434 NWMN_1507 accC acetyl-CoA biotin carboxylase 0.1 1.0   
SA1435 NWMN_1508 accB acetyl-CoA carboxylase, biotin carboxyl carrier 0.2 0.8   
SA1436 NWMN_1509  urea amidolyase-related protein 0.2 0.8   
SA1437 NWMN_1510  similar to allophanate hydrolase subunit 1 0.3 0.6 AATGAAAAGGTATTCAAT 
ATTGTATGCGATTTGAAT 
-34 GTG 
-86 ATG 
        
SA1516 NWMN_1586 phoP alkaline phosphatase synthesis transcriptional 
regulatory protein 
0.4 1.6   
        
SA1517 NWMN_1587 citC isocitrate dehyrogenase 0.1 1.0   
SA1518 NWMN_1588 citZ citrate synthase II 0.1 0.9 TGTGAAAGCCATTTCATA -27 ATG 
        
SA1528 NWMN_1600  universal stress protein family protein 0.3 1.0   
        
SA1531 NWMN_1603 ald alanine dehydrogenase 0.1 1.0 TTTGATTGCGCTTTCAAA -36 ATG 
        
SA1553 NWMN_1625 fhs formyltetrahydrofolate synthetase 0.4 1.1   
        
SA1609 NWMN_1681 pckA phosphoenolpyruvate carboxykinase [ATP] 0.2 0.7 AATGTAAAGGCTTACATT -27 ATG 
        
SA1617 NWMN_1688  similar to functionally unknown protein 0.3 1.3 TTTAAAAACTTTTTCAAA -274 ATG 
SA1618 NWMN_1689  conserved hypothetical protein 0.4 1.3   
        
SA1848 NWMN_1950 nrgA probabale ammonium transporter 0.4 0.8   
        
SA1889 NWMN_1990  hypothetical protein 0.4 1.0   
SA1890 NWMN_1991  conserved hypothetical protein 0.5 1.0   
        
SA1900 NWMN_2002  conserved hypothetical protein 0.4 1.0   
        
SA1932 NWMN_2034  similar to hypothetical protein T13D8.31 - Arabidopsis 
thaliana 
0.5 0.8   
        
   
 
SA1938 NWMN_2040 pdp pyrimidine nucleoside phosphorylase 0.5 1.0   
        
SA1968 NWMN_2065 arg arginase 0.4 1.0 ATGGTAAGCGCATACATT -35 ATG 
        
SA2121 NWMN_2231 hutI imidazolonepropionase 0.5 1.1   
SA2122 NWMN_2232 hutU urocanate hydratase 0.7 1.3 TATGTAACCGCATACATA -41  ATG 
        
SA2226 NWMN_2337  amino acid permease 0.2 0.9   
SA2227 NWMN_2337  truncated hypothetical protein, similar to D-serine/D-
alanine/glycine transporter 
0.1 0.9   
        
SA2311 NWMN_2421  NAD(P)H-flavin oxidoreductase 0.5 1.0 ATTGCAAACGGATTACTT -67 ATG 
        
SA2341 NWMN_2454 rocA 1-pyrroline-5-carboxylate dehydrogenase 0.2 1.2 AATGAAAGCGATTGCAAA -96 ATG 
        
SA2353 NWMN_2466  similar to secretory antigen precursor SsaA 0.5 1.0   
        
SA2356 NWMN_2469 isaA immunodominant antigen A 0.4 0.8   
        
SA2366 NWMN_2479  conserved hypothetical protein 0.4 1.1   
SA2367 NWMN_2480  conserevd hypothetical protein 0.4 1.0   
        
SA2378 NWMN_2491  conserved hypothetical protein 0.5 1.2   
        
SA2420 NWMN_2526 phoB alkaline phosphatase (EC 3.1.3.1) III precursor 0.2 1.4   
        
SA2479 NWMN_2585  conserved hypothetical protein 0.5 1.3   
        
SA2485 NWMN_2591  hypothetical protein 0.4 1.4   
        
SAS022 NWMN_0777  truncated conserved hypothetical protein 0.4 1.1   
        
SAS068 NWMN_1989  hypothetical protein 0.5 0.9   
        
SAS074 NWMN_2074  conserved hypothetical protein 0.5 0.6 CTTGAAAACGATTACAAA -47 ATG 
a 
Cellular main roles are in accordance with the N315 annotation of the DOGAN website (19) and/or the KEGG website (31). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 0.5 or ≥2 in the wild-type were considered to be regulated. 
c
 cre-site according to (48), allowing up to two mismatches. Palindromic parts are underlined. 
 
   
Supplementary Table 4: Genes with CcpA-dependent upregulation by glucose in the wild-type (factor of 2 or higher in wild type, factor of 
approximately 1, but above 0.5 in the mutant) 
ID   wt mut   
N315 Newman common Product
a
 +/-
b
 +/-
b
 cre
c
 Position 
SA0009 NWMN_0008 serS seryl-tRNA synthetase 2.6 0.8   
        
SA0143 NWMN_0094 adhE alcohol-acetaldehyde dehydrogenase 2.3 1.2   
        
SA0166 NWMN_0116  similar to nitrate transporter 2.8 1.1   
SA0167 NWMN_0117  similar to membrane lipoprotein SrpL 2.8 1.6 TATGGAAACATTTGCATT -50 ATG 
SA0168 NWMN_0118  similar to probable permease of ABC transporter 2.3 1.1   
        
SA0214 NWMN_0158 uhpT hexose phosphate transport protein 2.1 1.1   
        
SA0218 NWMN_0162 pflB formate acetyltransferase 2.7 1.6 TATGAAAACGTTAACATA -42 ATG 
SA0219 NWMN_0163 pflA formate acetyltransferase activating enzyme 2.3 1.6   
        
SA0230 NWMN_0174  conserved hypothetical protein 2.3 1.9   
        
SA0334 NWMN_0339  sec-independent protein translocase protein TatC 2.3 1.1   
SA0335 NWMN_0340  twin-arginine translocation protein TatA 2.2 1.4   
        
SA0373 NWMN_0378 xprT xanthine phosphoribosyltransferase 5.3 1.1   
SA0374 NWMN_0379 pbuX xanthine permease 7.2 1.1   
SA0375 NWMN_0380 guaB inositol-monophosphate dehydrogenase 3.6 1.2   
SA0376 NWMN_0381 guaA GMP synthase (glutamine-hydrolyzing) 3.3 1.2   
        
SA0411 NWMN_0418 ndhF NADH dehydrogenase subunit 5 2.5 0.9   
        
SA0412 NWMN_0419  conserved hypothetical protein 2.6 1.1   
        
SA0452 NWMN_0457 veg VEG protein homologue 3.1 1.0   
        
SA0461 NWMN_0466 mfd transcription-repair coupling factor 2.1 1.1   
SA0462 NWMN_0467  similar to low temperature requirement B protein 2.6 1.2   
        
SA0492 NWMN_0496  hypothetical protein 2.4 1.0   
        
   
 
SA0496 NWMN_0500 rplA 50S ribosomal protein L1 (BL1) 2.1 0.9   
SA0497 NWMN_0501 rplJ 50S ribosomal protein L10 (BL5) 2.6 1.6   
        
SA0577 NWMN_0592  similar to FimE recombinase 2.0 1.3   
        
SA0622 NWMN_0636 rbf similar to AraC/XylS family transcriptional regulator 2.2 1.0   
        
SA0655 NWMN_0669 fruA fructose specific permease 2.4 1.3 ATTGAAAAAGCATTCCAA -116 ATG 
        
SA0685 NWMN_0699 nrdI NrdI protein involved in ribonucleotide reductase 
function 
2.1 1.0   
SA0686 NWMN_0700 nrdE ribonuceloside diphosphate reductase major subunit 3.2 1.4   
SA0687 NWMN_0701 nrdF ribonucleoside-diphosphate reductase minor subunit 1.9 1.1   
        
SA0726 NWMN_0740 gapR glycolytic operon regulator 1.5 1.3   
SA0727 NWMN_0741 gap glyceraldehyde-3-phosphate dehydrogenase 1.7 1.6   
SA0728 NWMN_0742 pgk phosphoglycerate kinase 2.2 1.6   
SA0729 NWMN_0743 tpi triosephosphate isomerase 2.0 1.3   
SA0730 NWMN_0744 pgm 2, 3-diphosphoglycerate-independent phosphoglycerate 
mutase 
1.7 1.2   
SA0731 NWMN_0745 eno enolase (2-phosphoglycerate dehydrogenase) 1.4 1.3   
 
       
SA0769 NWMN_0780  D-methionine transport system ATP-binding protein 2.4 0.8   
SA0770 NWMN_0780  D-methionine transport system permease 2.4 1.0   
        
SA0922 NWMN_0938 purF phosphoribosylpyrophosphate amidotransferase PurF 2.7 1.2   
SA0923 NWMN_0939 purM phosphoribosylformylglycinamidine cyclo-ligase PurM 3.2 1.1   
SA0924 NWMN_0940 purN phosphoribosylglycinamide formyltransferase 3.2 0.9   
SA0925 NWMN_0941 purH bifunctional purine biosynthesis protein PurH 3.9 0.9   
SA0926 NWMN_0942 purD phosphoribosylamine-glycine ligase PurD 3.2 0.9   
        
SA0938 NWMN_0953 cydB cytochrome D ubiquinol oxidase subunit II homolog 2.0 1.1   
        
SA1009 NWMN_1075  similar to exotoxin 1 2.2 0.8   
SA1010 NWMN_1076  similar to exotoxin 4 2.3 0.6   
        
SA1200 NWMN_1280 trpG anthranilate synthase component II 2.3 1.0   
SA1201 NWMN_1281 trpD anthranilate phosphoribosyltransferase 2.0 1.0   
   
SA1202 NWMN_1282 trpC indole-3-glycerol phosphate synthase 2.0 0.9   
SA1203 NWMN_1283 trpF phosphoribosylanthranilate isomerase 2.2 1.0   
SA1204 NWMN_1284 trpB tryptophan synthase beta chain  1.8 1.0   
SA1205 NWMN_1285 trpA tryptophan synthase alpha chain  1.4 1.0   
        
SA1240 NWMN_1321  conserved hypothetical protein 2.4 1.2   
        
SA1241 NWMN_1322  similar to nitric-oxide reductase 2.3 1.2   
        
SA1270 NWMN_1347  similar to amino acid permease 2.0 1.1   
        
SA1295 NWMN_1373  conserved hypothetical protein 2.0 1.2   
        
        
SA1339 NWMN_1415 malR maltose operon transcriptional repressor 2.2 1.0 GTTGGAAGCGTTTTCCAA 
TATGCAATCGTTTGCACA 
- 27 ATG 
-94 ATG 
        
SA1442 NWMN_1515  similar to caffeoyl-CoA O-methyltransferase 2.0 0.8   
        
SA1493 NWMN_1563 hemD uroporphyrinogen III synthase 2.5 1.1   
SA1494 NWMN_1564 hemC porphobilinogen deaminase 2.8 0.9   
SA1495 NWMN_1565 hemX HemA concentration negative effector hemX 2.7 0.9   
        
SA1502 NWMN_1572 rplT 50S ribosomal protein L20 1.9 0.8   
SA1503 NWMN_1573 rpmI 50S ribosomal protein L35 2.1 0.8   
SA1504 NWMN_1574 infC translation initiation factor IF-3 infC 2.4 0.9   
        
SA1506 NWMN_1576 thrS threonyl-tRNA synthetase 1 2.2 1.4   
        
SA1608 NWMN_1680 metK S-adenosylmethionine synthetase 2.2 0.9 AATGTAAGCCTTTACATT -225 ATG 
        
SA1700 NWMN_1822 vraR two-component response regulator 2.2 0.8   
SA1701 NWMN_1823 vraS two-component sensor histidine kinase 2.5 0.7   
SA1702 NWMN_1824  conserved hypothetical protein 2.1 0.8   
        
        
SA1710 NWMN_1832  similar to DNA polymerase III, alpha chain PolC type 2.1 0.8   
        
SA1798 NWMN_1915  hypothetical protein (Bacteriophage phiN315) 2.0 1.7   
   
 
        
SA1849 NWMN_1951  conserved hypothetical protein 2.6 1.2   
SA1850 NWMN_1952  conserved hypothetical protein 2.1 1.3   
        
SA1870 NWMN_1971 rsbW anti-sigmaB factor 2.2 1.1   
        
SA1960 NWMN_2057 mtlF PTS system, mannitol specific IIBC component 6.4 0.2   
        
SA2053 NWMN_2158  glucose uptake protein homolog 2.5 1.2   
        
SA2183 NWMN_2295 narJ similar to nitrate reductase delta chain 2.1 0.7   
SA2184 NWMN_2296 narH nitrate reductase beta chain narH 2.4 0.7   
SA2186 NWMN_2298 nasF uroporphyrin-III C-methyl transferase 3.2 0.9   
SA2187 NWMN_2299 nasE assimilatory nitrite reductase 3.5 1.0   
SA2188 NWMN_2300 nasD nitrite reductase 2.4 0.9   
        
        
SA2234 NWMN_2344 opuCD probable glycine betaine/carnitine/choline ABC 
transporter (membrane part) OpuCD 
1.6 1.2   
SA2235 NWMN_2345 opuCC glycine betaine/carnitine/choline ABC transporter 
(osmoprotection) OpuCC 
1.9 1.2   
SA2236 NWMN_2346 opuCB probable glycine betaine/carnitine/choline ABC 
transporter (membrane part) OpuCB 
1.9 1.1   
SA2237 NWMN_2347 opuCA glycine betaine/carnitine/choline ABC transporter (ATP-
binding) OpuCA 
2.6 1.0 AATAAATTCGCTTTTAAA -311 ATG 
        
SA2239 NWMN_2349  similar to amino acid transporter 2.2 1.1   
        
SA2290 NWMN_2397 fnbB fibronectin-binding protein homolog 2.6 0.9   
        
SA2329 NWMN_2440 cidA conserved hypothetical protein 3.5 1.4 TATGGAAACGCTCTCTAA -107 ATG 
        
SA2443 NWMN_2549  similar to accessory secretory protein Asp3 2.0 1.2   
SA2444 NWMN_2550  similar to accessory secretory protein Asp2 2.3 1.3   
        
SAS091 NWMN_2600  hypothetical protein 9.7 1.9   
a
 Cellular main roles are in accordance with the N315 annotation of the DOGAN website (19) and/or the KEGG website (31). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 0.5 or ≥2 in the wild-type were considered to be regulated. 
c
 cre-site according to (48), allowing up to two mismatches. Palindromic parts are underlined. 
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Supplementary Table 5: Glycolysis/Gluconeogenes-associated genes 
ID   wt mut 
N315 Newman 
common 
Product
a
 
+/-
b
 +/-
b
 
SA0727 NWMN_0741 gap glyceraldehyde-3-phosphate 
dehydrogenase 
1.7 1.6 
SA0728 NWMN_0742 pgk phosphoglycerate kinase 2.2 1.6 
SA0729 NWMN_0743 tpi triosephosphate isomerase 2.0 1.3 
SA0730 NWMN_0744 pgm phosphoglycerate mut 1.7 1.2 
SA0731 NWMN_0745 eno enolase (2-phosphoglycerate 
dehydrogenase) 
1.4 1.3 
      
SA0823 NWNM_0833 pgi glucose-6-phosphate isomerase A 0.9 1.2 
      
SA0943-1 NWMN_0959 pdhA pyrubate dehydrogenase E1 component 
alpha subunit 
1.1 1.6 
SA0944 NWMN_0960 pdhB pyruvate dehydrogenase E1 component 
beta subunit 
0.9 1.6 
SA0945 NWMN_0961 pdhC dihydrolipoamide S-acetyltransferase 
component of pyruvate dehydrogenase 
complex E2 
0.7 1.4 
SA0946 NWMN_0962 pdhD dihydrolipoamide dehydrogenase 
component of pyruvate dehydrogenase 
E3 
0.7 1.1 
      
*SA1510 NWMN_1580 gapB glyceraldehyde 3-phosphate 
dehydrogenase 2 
no 
data 
no 
data 
      
SA1520 NWMN_1592 pykA pyruvate kinase 1.6 1.1 
SA1521 NWNM_1593 pfk  6-phosphofructokinase 0.6 1.1 
      
*SA1609 NWNM_1681 pckA phosphoenolpyruvate carboxykinase  0.2 0.7 
      
SA1927 NWMN_2029 fbaA fructose-bisphosphate aldolase 1.5 1.1 
      
SA2304 NWMN_2414 fbp fructose-bisphosphatase  1.0 0.6 
a
 Cellular main roles are in accordance with the N315 annotation of the DOGAN website (19) and/or 
the KEGG website (31). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
* Genes with cre-sites. 
Genes in bold letters are regulated. 
 
 
Supplementary Table 6: TCA-associated genes 
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
      
SA0545 NWMN_0550 pta phosphotransacetylase 1.1 1.2 
      
*SA0963 NWNM_0979 pycA pyruvate carboxylase 0.9 0.7 
      
SA0994 NWNM_2428 sdhC succinate dehydrogenase cytochrome 
b-558 
1.1 0.9 
SA0995 NWNM_2429 sdhA succinate dehydrogenase flavoprotein 
subunit 
0.8 1.0 
SA0996 NWNM_2430 sdhB succinate dehydrogenase iron-sulfur 
protein subunit 
0.5 1.0 
      
SA1088 NWNM_1155 sucC succinyl-CoA synthetase (beta 
subunit)  
0.2 1.4 
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SA1089 NWNM_1156 sucD succinyl-CoA synthetase (alpha 
subunit)  
0.2 1.5 
      
SA1184 NWNM_1263 citB aconitate hydratase  0.1 1.1 
      
SA1244 NWNM_1325 odhB/ 
sucB 
dihydrolipoamide 
succinyltransferase 0.1 1.1 
SA1245 NWNM_1326 
odhA/ 
sucA 2-oxoglutarate dehydrogenase E1  0.5 1.2 
      
SA1517 NWNM_1587 citC isocitrate dehyrogenase 0.1 1.0 
SA1518 NWNM_1588 citZ citrate synthase II 0.1 0.9 
      
SA1533 NWMN_1605 ackA acetate kinase homolog 1.3 1.1 
      
SA1554 NWMN_1626 acsA acetyl-CoA synthetase 0.8 0.9 
      
SA1669 NWNM_1743 citG/ 
fumC 
fumarate hydratase, class-II 0.6 1.1 
a
 Cellular main roles are in accordance with the N315 annotation of the DOGAN website (19) and/or 
the KEGG website (31). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
* Genes with cre-sites. 
Genes in bold letters are regulated. 
 
 
Supplementary Table 7: Genes of amino acid degradation regulated by CcpA 
ID   wt mut 
N315 Newman common Product
a
 +/-
b
 +/-
b
 
SA0008 NWMN_0007 hutH histidine ammonia-lyase 0.5 1.1 
      
*SA0162 NWMN_0113 aldA aldehyde dehydrogenase homologue 0.4 1.1 
      
*SA0818 NWMN_0827 rocD ornithine aminotransferase 0.3 1.0 
*SA0819 NWMN_0828 gudB NAD-specific glutamate dehydrogenase 0.2 1.1 
      
SA1150 NWMN_1217 glnA glutamine synthetase 0.5 1.3 
      
SA1365 NWMN_1439  glycine dehydrogenase 
(decarboxylating) subunit 2  
0.1 1.1 
SA1366 NWMN_1440  glycine dehydrogenase 
(decarboxylating) subunit 1 
0.1 1.2 
SA1367 NWMN_1441  aminomethyltransferase 0.2 1.4 
      
SA1531 NWMN_1603 ald alanine dehydrogenase 0.1 1.0 
      
*SA1968 NWMN_2065 arg(rocF) arginase 0.4 1.0 
      
SA2121 NWMN_2231 hutI imidazolonepropionase 0.5 1.1 
      
*SA2341 NWMN_2454 rocA 1-pyrroline-5-carboxylate 
dehydrogenase  
0.2 1.2 
a
 Cellular main roles are in accordance with the N315 annotation of the DOGAN website (19) and/or 
the KEGG website (31). 
b
 Comparison of gene expression with (+) and without (-) glucose, genes with a +/- glucose ratio of ≤ 
0.5 or ≥2 in the wild-type were considered to be regulated. 
* Genes with cre-sites. 
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5 Comments – Outlook 
The results of this study suggest that the S. aureus CcpA directly links virulence and 
resistance to carbohydrate utilization and make it an interesting target for further 
investigation.  
Our findings, that CcpA regulates the expression of fnbB, spa, isaA, the cap-genes and also 
biofilm formation reveal a possible role in host-pathogen interactions. This aspect could be 
further investigated in vitro by using matrix proteins or different host cell types to perform 
adhesion and internalization studies. In addition, in vivo assays could be carried out, 
employing various invertebrate and vertebrate animal models of infection. Of particular 
interest would be the use of diabetic mice. S. aureus is the predominant pathogen in foot 
infections of diabetic patients and blood glucose levels in diabetic patients often exceed 10 
mM, the amount of glucose we found to cause CcpA-dependent regulation of many S. 
aureus genes.  
It still remains unclear, why the agr-negative strain N315 exhibited such weak tst 
expression that was mostly insensitive to glucose-induced stimuli, in contrast to the other 
strains tested. As this strain seems to possess normal CcpA activity, the reason might be the 
missing RNAIII, which is known to induce tst-transcription. Therefore, the impact of RNAIII on 
CcpA-mediated regulation of tst needs to be investigated in more detail. Strain N315 also 
differs in terms of metabolism from other strains by being unable to catabolize acetate and 
having a truncated CcpC homologue, a protein known to regulate genes of the TCA cycle in 
B. subtilis. These aspects may have unknown consequences on tst expression, and also 
need further investigation.  
Analysis of the CcpA-regulon showed that in addition to the CcpA-mediated, glucose-induced 
regulation, an even higher number of genes was regulated by CcpA in a glucose-
independent way. A subject of further work could therefore include a closer investigation of 
the mechanisms by which this regulation is exerted.  
Our expression analysis focussed on the short term effects of glucose, triggered within 
approximately one generation. Possible secondary effects mediated by regulators, which are 
under the control of CcpA might only be seen after longer exposures to glucose. In addition, 
our analysis was carried out in the exponential growth phase, and CcpA-regulated genes 
which are expressed at later stages could not be identified. To extend the list of CcpA-
regulated genes, further microarray analyses could be carried out over time. To avoid 
secondary effects through changes in pH, glucose or oxygen levels, these investigations 
should ideally be performed under controlled conditions, using a fermenter. The data 
obtained could be combined with data from proteome analysis. To gain even more 
knowledge about the role of CcpA in the intermediary metabolism of S. aureus, 13C-tracer 
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experiments using wild type and ∆ccpA mutant could be carried out. So far, the development 
of an appropriate amino acid-free medium, which is needed for this method, was not 
successful and needs further investigation. 
Until now, the cre-consensus in S. aureus was assumed to be similar to the consensus 
sequences published for B. subtilis. To confirm this hypothesis or to find a more appropriate 
consensus for S. aureus, binding and/or foot printing assays could be carried out. This would 
imply the establishment of a functional in vitro system, including CcpA, HPr and a functional 
HPr kinase. This system might also be used for ChIP-on-chip, a technique which allows 
genome-wide location analysis of DNA sequences occupied by DNA-binding proteins, such 
as CcpA. 
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σB and the σB-dependent arlRS and yabJ-spoVG loci affect capsule formation in 
Staphylococcus aureus 
Collaboration 
Most clinical isolates of S. aureus are able to produce extracellular capsular polysaccharides 
(CPs). CPs are thought to contribute to pathogenesis, by protecting S. aureus against 
opsonophagocytic killing by polymorphonuclear leukocytes and by enhancing virulence in a 
number of animal models of staphylococcal infection. Expression of CPs is known to be 
influenced by various environmental signals in vitro and in vivo, and transcription of the cap 
operon was shown to be modulated by various regulators. Recent microarray analyses 
showed that capA transcription was also under the control of the alternative σ-factor σB. The 
lack of an apparent σB consensus sequence in the promoter region of capA suggested that 
σB regulates cap transcription indirectly. This study showed that capA transcription and 
capsule formation were regulated by σB over the σB-modulated arlRS and yabJ-spoVG loci.  
Contribution: Investigation of the effect of σB on arlRS expression, including Northern blot 
analyses, determination and interpretation of transcript sizes. 
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